"","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-212436","R-HSA-212436","Generic Transcription Pathway","31/47","481/2914",2.65633868277909e-14,1.33082568007233e-11,7.18609517341292e-12,"STAT1/CSNK2A1/RB1/CTNNB1/SMAD3/MAPK3/MEN1/MAPK14/SMAD4/AR/CSNK2A2/AKT2/MAPK1/CDK2/ESR1/YAP1/GATA2/MAX/STK11/EP300/ABL1/BRCA1/AKT1/E2F1/CDK5/NOTCH1/YY1/CDK1/AKT3/ATR/LAMTOR3",31
"R-HSA-73857","R-HSA-73857","RNA Polymerase II Transcription","31/47","499/2914",7.67429447858711e-14,1.92241076688607e-11,1.03804930578784e-11,"STAT1/CSNK2A1/RB1/CTNNB1/SMAD3/MAPK3/MEN1/MAPK14/SMAD4/AR/CSNK2A2/AKT2/MAPK1/CDK2/ESR1/YAP1/GATA2/MAX/STK11/EP300/ABL1/BRCA1/AKT1/E2F1/CDK5/NOTCH1/YY1/CDK1/AKT3/ATR/LAMTOR3",31
"R-HSA-1266738","R-HSA-1266738","Developmental Biology","27/47","397/2914",1.34248674934431e-12,2.241952871405e-10,1.21059331432101e-10,"CSNK2A1/STAT3/KDM6A/CTNNB1/SMAD3/MAPK3/MAPK14/SMAD4/NFKB1/CSNK2A2/AKT2/MAPK1/RELA/CDK2/GATA2/EP300/ABL1/AKT1/RPS6KA5/MAP2K1/E2F1/CDK5/NOTCH1/YY1/RPS6KA4/AKT3/RPS6KA2",27
"R-HSA-8878166","R-HSA-8878166","Transcriptional regulation by RUNX2","13/47","62/2914",3.989659186806e-12,4.99704813147451e-10,2.69826950265563e-10,"STAT1/RB1/MAPK3/SMAD4/AR/AKT2/MAPK1/ESR1/YAP1/ABL1/AKT1/CDK1/AKT3",13
"R-HSA-112409","R-HSA-112409","RAF-independent MAPK1/3 activation","9/47","23/2914",2.2873881345594e-11,2.29196291082852e-09,1.23759736964582e-09,"MAPK3/MAPK1/DUSP10/DUSP2/DUSP9/DUSP7/MAP2K1/DUSP8/CDK1",9
"R-HSA-5633007","R-HSA-5633007","Regulation of TP53 Activity","13/47","95/2914",1.16055201816843e-09,9.69060935170638e-08,5.23266436261906e-08,"CSNK2A1/MAPK14/CSNK2A2/AKT2/CDK2/STK11/EP300/BRCA1/AKT1/CDK5/CDK1/AKT3/ATR",13
"R-HSA-5675221","R-HSA-5675221","Negative regulation of MAPK pathway","8/47","34/2914",3.27032432081745e-08,2.34061783532792e-06,1.26386969992494e-06,"MAPK3/MAPK1/DUSP10/DUSP2/DUSP9/DUSP7/MAP2K1/DUSP8",8
"R-HSA-8941326","R-HSA-8941326","RUNX2 regulates bone development","7/47","24/2914",5.03994335484391e-08,3.156264525971e-06,1.70429663446696e-06,"RB1/MAPK3/SMAD4/AR/MAPK1/YAP1/ABL1",7
"R-HSA-1640170","R-HSA-1640170","Cell Cycle","17/47","249/2914",1.0696531115824e-07,5.95440232114201e-06,3.21521461610147e-06,"CSNK2A1/RB1/MAPK3/CSNK2A2/AKT2/MAPK1/CDK2/MAX/EP300/ABL1/BRCA1/AKT1/E2F1/CDK1/AKT3/ATR/PLK1",17
"R-HSA-69278","R-HSA-69278","Cell Cycle, Mitotic","15/47","191/2914",1.20093870727932e-07,6.01670292346939e-06,3.24885523969247e-06,"CSNK2A1/RB1/MAPK3/CSNK2A2/AKT2/MAPK1/CDK2/MAX/EP300/ABL1/AKT1/E2F1/CDK1/AKT3/PLK1",15
"R-HSA-3700989","R-HSA-3700989","Transcriptional Regulation by TP53","15/47","194/2914",1.48142982738557e-07,6.747239486547e-06,3.64332503002958e-06,"CSNK2A1/MAPK14/CSNK2A2/AKT2/CDK2/STK11/EP300/BRCA1/AKT1/E2F1/CDK5/CDK1/AKT3/ATR/LAMTOR3",15
"R-HSA-8940973","R-HSA-8940973","RUNX2 regulates osteoblast differentiation","6/47","19/2914",2.94006987135862e-07,1.22747917129222e-05,6.62805225385232e-06,"RB1/MAPK3/AR/MAPK1/YAP1/ABL1",6
"R-HSA-198753","R-HSA-198753","ERK/MAPK targets","6/47","21/2914",5.73880022779194e-07,2.21164531855674e-05,1.19422806359719e-05,"MAPK3/MAPK14/MAPK1/RPS6KA5/DUSP7/RPS6KA2",6
"R-HSA-2262752","R-HSA-2262752","Cellular responses to stress","14/47","187/2914",6.48533824303948e-07,2.32082461411627e-05,1.25318190109861e-05,"RB1/STAT3/MAPK3/MAPK14/AR/NFKB1/MAPK1/RELA/CDK2/EP300/E2F1/ATR/LAMTOR3/RPS6KA2",14
"R-HSA-8953897","R-HSA-8953897","Cellular responses to external stimuli","14/47","189/2914",7.40011662197719e-07,2.47163895174038e-05,1.33461752410396e-05,"RB1/STAT3/MAPK3/MAPK14/AR/NFKB1/MAPK1/RELA/CDK2/EP300/E2F1/ATR/LAMTOR3/RPS6KA2",14
"R-HSA-373760","R-HSA-373760","L1CAM interactions","8/47","53/2914",1.26940447305815e-06,3.97482275626333e-05,2.14629572089437e-05,"CSNK2A1/MAPK3/CSNK2A2/MAPK1/RPS6KA5/MAP2K1/RPS6KA4/RPS6KA2",8
"R-HSA-198725","R-HSA-198725","Nuclear Events (kinase and transcription factor activation)","6/47","24/2914",1.37243032042709e-06,4.04463288549397e-05,2.18399128389946e-05,"MAPK3/MAPK14/MAPK1/RPS6KA5/DUSP7/RPS6KA2",6
"R-HSA-69202","R-HSA-69202","Cyclin E associated events during G1/S transition ","7/47","39/2914",1.86677621674936e-06,5.17353343998519e-05,2.79356674876814e-05,"RB1/AKT2/CDK2/MAX/AKT1/E2F1/AKT3",7
"R-HSA-6804756","R-HSA-6804756","Regulation of TP53 Activity through Phosphorylation","8/47","56/2914",1.96201866985466e-06,5.17353343998519e-05,2.79356674876814e-05,"CSNK2A1/MAPK14/CSNK2A2/CDK2/STK11/BRCA1/CDK5/ATR",8
"R-HSA-69656","R-HSA-69656","Cyclin A:Cdk2-associated events at S phase entry","7/47","40/2914",2.23542567914385e-06,5.30642302668591e-05,2.8653234958678e-05,"RB1/AKT2/CDK2/MAX/AKT1/E2F1/AKT3",7
"R-HSA-2559583","R-HSA-2559583","Cellular Senescence","10/47","99/2914",2.36445880799508e-06,5.30642302668591e-05,2.8653234958678e-05,"RB1/STAT3/MAPK3/MAPK14/NFKB1/MAPK1/RELA/CDK2/E2F1/RPS6KA2",10
"R-HSA-453279","R-HSA-453279","Mitotic G1-G1/S phases","9/47","77/2914",2.3706448880222e-06,5.30642302668591e-05,2.8653234958678e-05,"RB1/AKT2/CDK2/MAX/ABL1/AKT1/E2F1/CDK1/AKT3",9
"R-HSA-168142","R-HSA-168142","Toll Like Receptor 10 (TLR10) Cascade","9/47","78/2914",2.647915681979e-06,5.30642302668591e-05,2.8653234958678e-05,"MAPK3/MAPK14/NFKB1/MAPK1/RELA/RPS6KA5/DUSP7/MAP2K1/RPS6KA2",9
"R-HSA-168176","R-HSA-168176","Toll Like Receptor 5 (TLR5) Cascade","9/47","78/2914",2.647915681979e-06,5.30642302668591e-05,2.8653234958678e-05,"MAPK3/MAPK14/NFKB1/MAPK1/RELA/RPS6KA5/DUSP7/MAP2K1/RPS6KA2",9
"R-HSA-975871","R-HSA-975871","MyD88 cascade initiated on plasma membrane","9/47","78/2914",2.647915681979e-06,5.30642302668591e-05,2.8653234958678e-05,"MAPK3/MAPK14/NFKB1/MAPK1/RELA/RPS6KA5/DUSP7/MAP2K1/RPS6KA2",9
"R-HSA-6807070","R-HSA-6807070","PTEN Regulation","8/47","59/2914",2.95372936413426e-06,5.69160927473563e-05,3.07331354891703e-05,"CSNK2A1/MAPK3/CSNK2A2/AKT2/MAPK1/AKT1/AKT3/LAMTOR3",8
"R-HSA-450294","R-HSA-450294","MAP kinase activation","8/47","60/2914",3.36718367239353e-06,6.02485364238985e-05,3.25325640528247e-05,"MAPK3/MAPK14/NFKB1/MAPK1/RPS6KA5/DUSP7/MAP2K1/RPS6KA2",8
"R-HSA-69206","R-HSA-69206","G1/S Transition","8/47","60/2914",3.36718367239353e-06,6.02485364238985e-05,3.25325640528247e-05,"RB1/AKT2/CDK2/MAX/AKT1/E2F1/CDK1/AKT3",8
"R-HSA-975138","R-HSA-975138","TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation","9/47","83/2914",4.49471280763381e-06,7.76500385042944e-05,4.19288998752047e-05,"MAPK3/MAPK14/NFKB1/MAPK1/RELA/RPS6KA5/DUSP7/MAP2K1/RPS6KA2",9
"R-HSA-168181","R-HSA-168181","Toll Like Receptor 7/8 (TLR7/8) Cascade","9/47","84/2914",4.97401090715479e-06,8.01645320818564e-05,4.32866577267299e-05,"MAPK3/MAPK14/NFKB1/MAPK1/RELA/RPS6KA5/DUSP7/MAP2K1/RPS6KA2",9
"R-HSA-975155","R-HSA-975155","MyD88 dependent cascade initiated on endosome","9/47","84/2914",4.97401090715479e-06,8.01645320818564e-05,4.32866577267299e-05,"MAPK3/MAPK14/NFKB1/MAPK1/RELA/RPS6KA5/DUSP7/MAP2K1/RPS6KA2",9
"R-HSA-2559582","R-HSA-2559582","Senescence-Associated Secretory Phenotype (SASP)","7/47","45/2914",5.12028947429023e-06,8.01645320818564e-05,4.32866577267299e-05,"STAT3/MAPK3/NFKB1/MAPK1/RELA/CDK2/RPS6KA2",7
"R-HSA-448424","R-HSA-448424","Interleukin-17 signaling","8/47","64/2914",5.54975861516578e-06,8.21346959775494e-05,4.43504924177544e-05,"MAPK3/MAPK14/NFKB1/MAPK1/RPS6KA5/DUSP7/MAP2K1/RPS6KA2",8
"R-HSA-450282","R-HSA-450282","MAPK targets/ Nuclear events mediated by MAP kinases","6/47","30/2914",5.62824997335144e-06,8.21346959775494e-05,4.43504924177544e-05,"MAPK3/MAPK14/MAPK1/RPS6KA5/DUSP7/RPS6KA2",6
"R-HSA-166058","R-HSA-166058","MyD88:MAL(TIRAP) cascade initiated on plasma membrane","9/47","86/2914",6.0658358306773e-06,8.21346959775494e-05,4.43504924177544e-05,"MAPK3/MAPK14/NFKB1/MAPK1/RELA/RPS6KA5/DUSP7/MAP2K1/RPS6KA2",9
"R-HSA-168138","R-HSA-168138","Toll Like Receptor 9 (TLR9) Cascade","9/47","86/2914",6.0658358306773e-06,8.21346959775494e-05,4.43504924177544e-05,"MAPK3/MAPK14/NFKB1/MAPK1/RELA/RPS6KA5/DUSP7/MAP2K1/RPS6KA2",9
"R-HSA-168188","R-HSA-168188","Toll Like Receptor TLR6:TLR2 Cascade","9/47","86/2914",6.0658358306773e-06,8.21346959775494e-05,4.43504924177544e-05,"MAPK3/MAPK14/NFKB1/MAPK1/RELA/RPS6KA5/DUSP7/MAP2K1/RPS6KA2",9
"R-HSA-168164","R-HSA-168164","Toll Like Receptor 3 (TLR3) Cascade","9/47","87/2914",6.68496906272439e-06,8.3729237510623e-05,4.5211501292636e-05,"MAPK3/MAPK14/NFKB1/MAPK1/RELA/RPS6KA5/DUSP7/MAP2K1/RPS6KA2",9
"R-HSA-168179","R-HSA-168179","Toll Like Receptor TLR1:TLR2 Cascade","9/47","87/2914",6.68496906272439e-06,8.3729237510623e-05,4.5211501292636e-05,"MAPK3/MAPK14/NFKB1/MAPK1/RELA/RPS6KA5/DUSP7/MAP2K1/RPS6KA2",9
"R-HSA-181438","R-HSA-181438","Toll Like Receptor 2 (TLR2) Cascade","9/47","87/2914",6.68496906272439e-06,8.3729237510623e-05,4.5211501292636e-05,"MAPK3/MAPK14/NFKB1/MAPK1/RELA/RPS6KA5/DUSP7/MAP2K1/RPS6KA2",9
"R-HSA-166520","R-HSA-166520","Signaling by NTRKs","9/47","89/2914",8.08761651284703e-06,9.8826728608204e-05,5.3363734115576e-05,"STAT3/MAPK3/MAPK14/MAPK1/RPS6KA5/DUSP7/MAP2K1/CDK5/RPS6KA2",9
"R-HSA-166166","R-HSA-166166","MyD88-independent TLR4 cascade ","9/47","90/2914",8.87890670710856e-06,0.000102784629695352,5.55008925973431e-05,"MAPK3/MAPK14/NFKB1/MAPK1/RELA/RPS6KA5/DUSP7/MAP2K1/RPS6KA2",9
"R-HSA-937061","R-HSA-937061","TRIF(TICAM1)-mediated TLR4 signaling ","9/47","90/2914",8.87890670710856e-06,0.000102784629695352,5.55008925973431e-05,"MAPK3/MAPK14/NFKB1/MAPK1/RELA/RPS6KA5/DUSP7/MAP2K1/RPS6KA2",9
"R-HSA-109606","R-HSA-109606","Intrinsic Pathway for Apoptosis","7/47","49/2914",9.23215236784598e-06,0.000102784629695352,5.55008925973431e-05,"STAT3/MAPK3/AKT2/MAPK1/AKT1/E2F1/AKT3",7
"R-HSA-9614085","R-HSA-9614085","FOXO-mediated transcription","7/47","49/2914",9.23215236784598e-06,0.000102784629695352,5.55008925973431e-05,"SMAD3/SMAD4/AKT2/STK11/EP300/AKT1/AKT3",7
"R-HSA-187037","R-HSA-187037","Signaling by NTRK1 (TRKA)","8/47","70/2914",1.10075736368161e-05,0.000119886834609671,6.47356161249827e-05,"STAT3/MAPK3/MAPK14/MAPK1/RPS6KA5/DUSP7/MAP2K1/RPS6KA2",8
"R-HSA-445144","R-HSA-445144","Signal transduction by L1","5/47","20/2914",1.13672398127619e-05,0.000121169939280717,6.54284576008914e-05,"CSNK2A1/MAPK3/CSNK2A2/MAPK1/MAP2K1",5
"R-HSA-186712","R-HSA-186712","Regulation of beta-cell development","5/47","24/2914",2.96917235288276e-05,0.000303582724243727,0.000163926379095783,"AKT2/EP300/AKT1/NOTCH1/AKT3",5
"R-HSA-9634638","R-HSA-9634638","Estrogen-dependent nuclear events downstream of ESR-membrane signaling","5/47","24/2914",2.96917235288276e-05,0.000303582724243727,0.000163926379095783,"MAPK3/AKT2/MAPK1/AKT1/AKT3",5
"R-HSA-8948751","R-HSA-8948751","Regulation of PTEN stability and activity","5/47","25/2914",3.66686566652917e-05,0.000367419939786223,0.00019839673185221,"CSNK2A1/CSNK2A2/AKT2/AKT1/AKT3",5
"R-HSA-166016","R-HSA-166016","Toll Like Receptor 4 (TLR4) Cascade","9/47","110/2914",4.58855475680498e-05,0.000449121164673085,0.000242513161720733,"MAPK3/MAPK14/NFKB1/MAPK1/RELA/RPS6KA5/DUSP7/MAP2K1/RPS6KA2",9
"R-HSA-5663202","R-HSA-5663202","Diseases of signal transduction","14/47","268/2914",4.66153703852304e-05,0.000449121164673085,0.000242513161720733,"STAT1/STAT3/CTNNB1/SMAD3/MAPK3/SMAD4/AKT2/MAPK1/ESR1/EP300/AKT1/MAP2K1/NOTCH1/AKT3",14
"R-HSA-6804758","R-HSA-6804758","Regulation of TP53 Activity through Acetylation","4/47","14/2914",5.2880691220596e-05,0.000495410915625362,0.000267508362886265,"AKT2/EP300/AKT1/AKT3",4
"R-HSA-9006934","R-HSA-9006934","Signaling by Receptor Tyrosine Kinases","16/47","347/2914",5.35269219260474e-05,0.000495410915625362,0.000267508362886265,"STAT1/STAT3/CTNNB1/MAPK3/MAPK14/AKT2/MAPK1/ESR1/YAP1/AKT1/RPS6KA5/DUSP7/MAP2K1/CDK5/AKT3/RPS6KA2",16
"R-HSA-9616222","R-HSA-9616222","Transcriptional regulation of granulopoiesis","5/47","27/2914",5.43864278630637e-05,0.000495410915625362,0.000267508362886265,"STAT3/CDK2/GATA2/EP300/E2F1",5
"R-HSA-5684996","R-HSA-5684996","MAPK1/MAPK3 signaling","11/47","177/2914",7.75715655447309e-05,0.000674558030057883,0.000364242911492543,"MAPK3/MAPK1/DUSP10/DUSP2/DUSP9/DUSP7/MAP2K1/DUSP8/CDK1/WDR83/LAMTOR3",11
"R-HSA-6804757","R-HSA-6804757","Regulation of TP53 Degradation","5/47","29/2914",7.80925463939265e-05,0.000674558030057883,0.000364242911492543,"AKT2/CDK2/AKT1/CDK1/AKT3",5
"R-HSA-6806003","R-HSA-6806003","Regulation of TP53 Expression and Degradation","5/47","29/2914",7.80925463939265e-05,0.000674558030057883,0.000364242911492543,"AKT2/CDK2/AKT1/CDK1/AKT3",5
"R-HSA-69242","R-HSA-69242","S Phase","7/47","71/2914",0.000109344869337009,0.000928504737929519,0.000501367197495297,"RB1/AKT2/CDK2/MAX/AKT1/E2F1/AKT3",7
"R-HSA-9607240","R-HSA-9607240","FLT3 Signaling","11/47","188/2914",0.000134643251421646,0.00112427114937074,0.000607075712550227,"MAPK3/AKT2/MAPK1/DUSP10/DUSP2/DUSP9/DUSP7/MAP2K1/DUSP8/WDR83/LAMTOR3",11
"R-HSA-168898","R-HSA-168898","Toll-like Receptor Cascades","9/47","127/2914",0.000142637058792331,0.00117149453204849,0.000632575049346487,"MAPK3/MAPK14/NFKB1/MAPK1/RELA/RPS6KA5/DUSP7/MAP2K1/RPS6KA2",9
"R-HSA-68875","R-HSA-68875","Mitotic Prophase","5/47","33/2914",0.000148706795639828,0.00120164684863796,0.000648856476730657,"RB1/MAPK3/MAPK1/CDK1/PLK1",5
"R-HSA-109581","R-HSA-109581","Apoptosis","8/47","101/2914",0.000161770390978871,0.00128645977587959,0.000694653140878359,"STAT3/CTNNB1/MAPK3/AKT2/MAPK1/AKT1/E2F1/AKT3",8
"R-HSA-8878159","R-HSA-8878159","Transcriptional regulation by RUNX3","6/47","53/2914",0.000164473599299364,0.00128751989451533,0.000695225575985799,"CTNNB1/SMAD3/SMAD4/YAP1/EP300/NOTCH1",6
"R-HSA-5674135","R-HSA-5674135","MAP2K and MAPK activation","5/47","34/2914",0.000172252392700212,0.00132766844219702,0.000716904695124769,"MAPK3/MAPK1/MAP2K1/WDR83/LAMTOR3",5
"R-HSA-5357801","R-HSA-5357801","Programmed Cell Death","8/47","103/2914",0.000185748074659284,0.00140999674855002,0.000761359731857035,"STAT3/CTNNB1/MAPK3/AKT2/MAPK1/AKT1/E2F1/AKT3",8
"R-HSA-1538133","R-HSA-1538133","G0 and Early G1","4/47","19/2914",0.0001929717934884,0.00142174806673071,0.000767705122701531,"CDK2/MAX/E2F1/CDK1",4
"R-HSA-5621575","R-HSA-5621575","CD209 (DC-SIGN) signaling","4/47","19/2914",0.0001929717934884,0.00142174806673071,0.000767705122701531,"NFKB1/RELA/EP300/RPS6KA5",4
"R-HSA-437239","R-HSA-437239","Recycling pathway of L1","4/47","20/2914",0.000238372931907311,0.00173079476645743,0.00093458189931623,"MAPK1/RPS6KA5/RPS6KA4/RPS6KA2",4
"R-HSA-5683057","R-HSA-5683057","MAPK family signaling cascades","11/47","202/2914",0.000256460913067094,0.0018260944047848,0.000986041101018372,"MAPK3/MAPK1/DUSP10/DUSP2/DUSP9/DUSP7/MAP2K1/DUSP8/CDK1/WDR83/LAMTOR3",11
"R-HSA-8939211","R-HSA-8939211","ESR-mediated signaling","8/47","108/2914",0.000258787829819802,0.0018260944047848,0.000986041101018372,"MAPK3/AKT2/MAPK1/ESR1/EP300/AKT1/YY1/AKT3",8
"R-HSA-5673001","R-HSA-5673001","RAF/MAP kinase cascade","10/47","171/2914",0.000289198221152171,0.00201233762218386,0.00108660735140509,"MAPK3/MAPK1/DUSP10/DUSP2/DUSP9/DUSP7/MAP2K1/DUSP8/WDR83/LAMTOR3",10
"R-HSA-1643685","R-HSA-1643685","Disease","17/47","443/2914",0.000299078772957622,0.00205258171577765,0.00110833806272687,"STAT1/STAT3/CTNNB1/SMAD3/MAPK3/SMAD4/NFKB1/AKT2/MAPK1/RELA/ESR1/EP300/AKT1/MAP2K1/CDK5/NOTCH1/AKT3",17
"R-HSA-8878171","R-HSA-8878171","Transcriptional regulation by RUNX1","7/47","86/2914",0.000367954414620005,0.00249115083411652,0.00134515340764355,"CSNK2A1/CSNK2A2/ESR1/YAP1/GATA2/EP300/ABL1",7
"R-HSA-2559585","R-HSA-2559585","Oncogene Induced Senescence","4/47","23/2914",0.000420454063923812,0.00276586236406439,0.0014934901304014,"RB1/MAPK3/MAPK1/E2F1",4
"R-HSA-9009391","R-HSA-9009391","Extra-nuclear estrogen signaling","6/47","63/2914",0.000430987192720419,0.00276586236406439,0.0014934901304014,"MAPK3/AKT2/MAPK1/ESR1/AKT1/AKT3",6
"R-HSA-110056","R-HSA-110056","MAPK3 (ERK1) activation","3/47","10/2914",0.000436133985551071,0.00276586236406439,0.0014934901304014,"MAPK3/MAP2K1/CDK1",3
"R-HSA-450341","R-HSA-450341","Activation of the AP-1 family of transcription factors","3/47","10/2914",0.000436133985551071,0.00276586236406439,0.0014934901304014,"MAPK3/MAPK14/MAPK1",3
"R-HSA-6804759","R-HSA-6804759","Regulation of TP53 Activity through Association with Co-factors","3/47","10/2914",0.000436133985551071,0.00276586236406439,0.0014934901304014,"AKT2/AKT1/AKT3",3
"R-HSA-982772","R-HSA-982772","Growth hormone receptor signaling","4/47","24/2914",0.000498606532002808,0.00312252340666759,0.00168607735164108,"STAT1/STAT3/MAPK3/MAPK1",4
"R-HSA-5218920","R-HSA-5218920","VEGFR2 mediated vascular permeability","4/47","25/2914",0.000586594698733764,0.00349467996175244,0.00188703172637961,"CTNNB1/AKT2/AKT1/AKT3",4
"R-HSA-113510","R-HSA-113510","E2F mediated regulation of DNA replication","3/47","11/2914",0.000592909773950014,0.00349467996175244,0.00188703172637961,"RB1/E2F1/CDK1",3
"R-HSA-1358803","R-HSA-1358803","Downregulation of ERBB2:ERBB3 signaling","3/47","11/2914",0.000592909773950014,0.00349467996175244,0.00188703172637961,"AKT2/AKT1/AKT3",3
"R-HSA-210745","R-HSA-210745","Regulation of gene expression in beta cells","3/47","11/2914",0.000592909773950014,0.00349467996175244,0.00188703172637961,"AKT2/AKT1/AKT3",3
"R-HSA-9614399","R-HSA-9614399","Regulation of localization of FOXO transcription factors","3/47","11/2914",0.000592909773950014,0.00349467996175244,0.00188703172637961,"AKT2/AKT1/AKT3",3
"R-HSA-5688426","R-HSA-5688426","Deubiquitination","8/47","124/2914",0.000666038764594138,0.00388006303560073,0.00209512805998401,"SMAD3/SMAD4/AR/ESR1/EP300/BRCA1/YY1/CDK1",8
"R-HSA-170968","R-HSA-170968","Frs2-mediated activation","3/47","12/2914",0.000781620371008933,0.00444990688494858,0.00240282817403464,"MAPK3/MAPK1/MAP2K1",3
"R-HSA-202670","R-HSA-202670","ERKs are inactivated","3/47","12/2914",0.000781620371008933,0.00444990688494858,0.00240282817403464,"MAPK3/MAPK1/DUSP7",3
"R-HSA-165159","R-HSA-165159","mTOR signalling","4/47","27/2914",0.000794781155485012,0.00447399279660664,0.00241583390845237,"AKT2/STK11/AKT1/LAMTOR3",4
"R-HSA-195258","R-HSA-195258","RHO GTPase Effectors","8/47","130/2914",0.000913307708419651,0.00508407957686939,0.00274526410600995,"CTNNB1/MAPK3/MEN1/MAPK14/AR/MAPK1/ABL1/PLK1",8
"R-HSA-169893","R-HSA-169893","Prolonged ERK activation events","3/47","13/2914",0.00100463962106864,0.00541209086188588,0.00292238124068635,"MAPK3/MAPK1/MAP2K1",3
"R-HSA-198323","R-HSA-198323","AKT phosphorylates targets in the cytosol","3/47","13/2914",0.00100463962106864,0.00541209086188588,0.00292238124068635,"AKT2/AKT1/AKT3",3
"R-HSA-8876198","R-HSA-8876198","RAB GEFs exchange GTP for GDP on RABs","3/47","13/2914",0.00100463962106864,0.00541209086188588,0.00292238124068635,"AKT2/AKT1/AKT3",3
"R-HSA-114452","R-HSA-114452","Activation of BH3-only proteins","4/47","29/2914",0.00105046229138629,0.00559874051047376,0.00302316695281386,"AKT2/AKT1/E2F1/AKT3",4
"R-HSA-6791312","R-HSA-6791312","TP53 Regulates Transcription of Cell Cycle Genes","4/47","30/2914",0.00119782796611064,0.00631696643180454,0.003410989332858,"CDK2/EP300/E2F1/CDK1",4
"R-HSA-9006931","R-HSA-9006931","Signaling by Nuclear Receptors","8/47","136/2914",0.00122993735225197,0.00638422632993169,0.0034473078407237,"MAPK3/AKT2/MAPK1/ESR1/EP300/AKT1/YY1/AKT3",8
"R-HSA-68886","R-HSA-68886","M Phase","7/47","105/2914",0.00123606777246182,0.00638422632993169,0.0034473078407237,"CSNK2A1/RB1/MAPK3/CSNK2A2/MAPK1/CDK1/PLK1",7
"R-HSA-3769402","R-HSA-3769402","Deactivation of the beta-catenin transactivating complex","4/47","31/2914",0.00135912627166306,0.00692515782759419,0.00373939607457024,"CTNNB1/MEN1/AKT2/AKT1",4
"R-HSA-1257604","R-HSA-1257604","PIP3 activates AKT signaling","9/47","172/2914",0.00136844436114137,0.00692515782759419,0.00373939607457024,"CSNK2A1/MAPK3/CSNK2A2/AKT2/MAPK1/ESR1/AKT1/AKT3/LAMTOR3",9
"R-HSA-201681","R-HSA-201681","TCF dependent signaling in response to WNT","7/47","108/2914",0.00145978668324284,0.00731353128304662,0.00394910713256221,"CSNK2A1/CTNNB1/MEN1/CSNK2A2/AKT2/EP300/AKT1",7
"R-HSA-111447","R-HSA-111447","Activation of BAD and translocation to mitochondria ","3/47","15/2914",0.00156244792678773,0.00775036050812525,0.00418498298264143,"AKT2/AKT1/AKT3",3
"R-HSA-449147","R-HSA-449147","Signaling by Interleukins","13/47","332/2914",0.00163230606243634,0.00801750330667261,0.00432923279717378,"STAT1/STAT3/SMAD3/MAPK3/MAPK14/NFKB1/MAPK1/RELA/AKT1/RPS6KA5/DUSP7/MAP2K1/RPS6KA2",13
"R-HSA-187687","R-HSA-187687","Signalling to ERKs","4/47","33/2914",0.00172626179868556,0.00839667146739289,0.0045339732474419,"MAPK3/MAPK14/MAPK1/MAP2K1",4
"R-HSA-422475","R-HSA-422475","Axon guidance","11/47","254/2914",0.00180938237902728,0.0087163516528141,0.00470659181589079,"CSNK2A1/MAPK3/MAPK14/CSNK2A2/MAPK1/ABL1/RPS6KA5/MAP2K1/CDK5/RPS6KA4/RPS6KA2",11
"R-HSA-392451","R-HSA-392451","G beta:gamma signalling through PI3Kgamma","3/47","16/2914",0.00190134539831611,0.00898654759015446,0.00485249024197856,"AKT2/AKT1/AKT3",3
"R-HSA-5668599","R-HSA-5668599","RHO GTPases Activate NADPH Oxidases","3/47","16/2914",0.00190134539831611,0.00898654759015446,0.00485249024197856,"MAPK3/MAPK14/MAPK1",3
"R-HSA-1834949","R-HSA-1834949","Cytosolic sensors of pathogen-associated DNA ","4/47","34/2914",0.00193346305281694,0.009052943826741,0.0048883423962022,"CTNNB1/NFKB1/RELA/EP300",4
"R-HSA-5628897","R-HSA-5628897","TP53 Regulates Metabolic Genes","4/47","35/2914",0.0021573230278506,0.0100075818236403,0.00540382083974272,"AKT2/AKT1/AKT3/LAMTOR3",4
"R-HSA-9013695","R-HSA-9013695","NOTCH4 Intracellular Domain Regulates Transcription","3/47","17/2914",0.00228277629006096,0.010492393773583,0.00566560605065831,"SMAD3/EP300/NOTCH1",3
"R-HSA-69273","R-HSA-69273","Cyclin A/B1/B2 associated events during G2/M transition","3/47","18/2914",0.00270849898435431,0.0119031402733466,0.00642737062769212,"CDK2/CDK1/PLK1",3
"R-HSA-881907","R-HSA-881907","Gastrin-CREB signalling pathway via PKC and MAPK","3/47","18/2914",0.00270849898435431,0.0119031402733466,0.00642737062769212,"MAPK3/MAPK1/RPS6KA2",3
"R-HSA-8939243","R-HSA-8939243","RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known","3/47","18/2914",0.00270849898435431,0.0119031402733466,0.00642737062769212,"CSNK2A1/CSNK2A2/EP300",3
"R-HSA-8953750","R-HSA-8953750","Transcriptional Regulation by E2F6","3/47","18/2914",0.00270849898435431,0.0119031402733466,0.00642737062769212,"MAX/BRCA1/E2F1",3
"R-HSA-9013508","R-HSA-9013508","NOTCH3 Intracellular Domain Regulates Transcription","3/47","18/2914",0.00270849898435431,0.0119031402733466,0.00642737062769212,"STAT1/EP300/NOTCH1",3
"R-HSA-389513","R-HSA-389513","CTLA4 inhibitory signaling","3/47","19/2914",0.00318016033264167,0.0138544376230737,0.00748101789921198,"AKT2/AKT1/AKT3",3
"R-HSA-9013694","R-HSA-9013694","Signaling by NOTCH4","4/47","40/2914",0.00354977058298724,0.0153313367420397,0.00827850308373612,"SMAD3/EP300/AKT1/NOTCH1",4
"R-HSA-9006925","R-HSA-9006925","Intracellular signaling by second messengers","9/47","201/2914",0.00402940125823275,0.0172541028237146,0.00931674424980493,"CSNK2A1/MAPK3/CSNK2A2/AKT2/MAPK1/ESR1/AKT1/AKT3/LAMTOR3",9
"R-HSA-389357","R-HSA-389357","CD28 dependent PI3K/Akt signaling","3/47","21/2914",0.0042673504322423,0.0178799728878174,0.00965469698953476,"AKT2/AKT1/AKT3",3
"R-HSA-397795","R-HSA-397795","G-protein beta:gamma signalling","3/47","21/2914",0.0042673504322423,0.0178799728878174,0.00965469698953476,"AKT2/AKT1/AKT3",3
"R-HSA-453274","R-HSA-453274","Mitotic G2-G2/M phases","5/47","68/2914",0.00428262823660297,0.0178799728878174,0.00965469698953476,"CDK2/EP300/E2F1/CDK1/PLK1",5
"R-HSA-199418","R-HSA-199418","Negative regulation of the PI3K/AKT network","6/47","99/2914",0.00458630236357023,0.0189895659846999,0.0102538469546546,"MAPK3/AKT2/MAPK1/ESR1/AKT1/AKT3",6
"R-HSA-1500620","R-HSA-1500620","Meiosis","3/47","22/2914",0.00488564744764674,0.0195816749701681,0.010573569634065,"CDK2/BRCA1/ATR",3
"R-HSA-201722","R-HSA-201722","Formation of the beta-catenin:TCF transactivating complex","3/47","22/2914",0.00488564744764674,0.0195816749701681,0.010573569634065,"CTNNB1/MEN1/EP300",3
"R-HSA-442742","R-HSA-442742","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","3/47","22/2914",0.00488564744764674,0.0195816749701681,0.010573569634065,"MAPK3/MAPK1/RPS6KA2",3
"R-HSA-525793","R-HSA-525793","Myogenesis","3/47","22/2914",0.00488564744764674,0.0195816749701681,0.010573569634065,"CTNNB1/MAPK14/ABL1",3
"R-HSA-2559580","R-HSA-2559580","Oxidative Stress Induced Senescence","4/47","44/2914",0.0050301357849633,0.020000778002116,0.0107998738240231,"MAPK3/MAPK14/MAPK1/E2F1",4
"R-HSA-1912408","R-HSA-1912408","Pre-NOTCH Transcription and Translation","3/47","23/2914",0.00555542645520518,0.0217442863598265,0.0117413207153596,"EP300/E2F1/NOTCH1",3
"R-HSA-5685938","R-HSA-5685938","HDR through Single Strand Annealing (SSA)","3/47","23/2914",0.00555542645520518,0.0217442863598265,0.0117413207153596,"ABL1/BRCA1/ATR",3
"R-HSA-157118","R-HSA-157118","Signaling by NOTCH","6/47","104/2914",0.00584421830245261,0.0226973129420834,0.0122559290390071,"STAT1/SMAD3/EP300/AKT1/E2F1/NOTCH1",6
"R-HSA-1474165","R-HSA-1474165","Reproduction","3/47","24/2914",0.00627782930137694,0.0236480637593222,0.0127693085117046,"CDK2/BRCA1/ATR",3
"R-HSA-2173796","R-HSA-2173796","SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription","3/47","24/2914",0.00627782930137694,0.0236480637593222,0.0127693085117046,"SMAD3/MEN1/SMAD4",3
"R-HSA-5674400","R-HSA-5674400","Constitutive Signaling by AKT1 E17K in Cancer","3/47","24/2914",0.00627782930137694,0.0236480637593222,0.0127693085117046,"AKT2/AKT1/AKT3",3
"R-HSA-8863795","R-HSA-8863795","Downregulation of ERBB2 signaling","3/47","24/2914",0.00627782930137694,0.0236480637593222,0.0127693085117046,"AKT2/AKT1/AKT3",3
"R-HSA-5663213","R-HSA-5663213","RHO GTPases Activate WASPs and WAVEs","3/47","25/2914",0.00705390674719191,0.0259853476495819,0.0140313779723554,"MAPK3/MAPK1/ABL1",3
"R-HSA-8864260","R-HSA-8864260","Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors","3/47","25/2914",0.00705390674719191,0.0259853476495819,0.0140313779723554,"ESR1/EP300/YY1",3
"R-HSA-9007101","R-HSA-9007101","Rab regulation of trafficking","3/47","25/2914",0.00705390674719191,0.0259853476495819,0.0140313779723554,"AKT2/AKT1/AKT3",3
"R-HSA-3371556","R-HSA-3371556","Cellular response to heat stress","4/47","49/2914",0.0074023761520057,0.0270700033004004,0.014617062397737,"MAPK3/MAPK1/EP300/ATR",4
"R-HSA-5617472","R-HSA-5617472","Activation of anterior HOX genes in hindbrain development during early embryogenesis","3/47","27/2914",0.00877085163032144,0.0313871190485074,0.0169481869849068,"KDM6A/EP300/YY1",3
"R-HSA-5619507","R-HSA-5619507","Activation of HOX genes during differentiation","3/47","27/2914",0.00877085163032144,0.0313871190485074,0.0169481869849068,"KDM6A/EP300/YY1",3
"R-HSA-8939236","R-HSA-8939236","RUNX1 regulates transcription of genes involved in differentiation of HSCs","3/47","27/2914",0.00877085163032144,0.0313871190485074,0.0169481869849068,"YAP1/GATA2/ABL1",3
"R-HSA-446652","R-HSA-446652","Interleukin-1 family signaling","5/47","82/2914",0.00947356511916792,0.0336613909553413,0.018176231695604,"STAT3/SMAD3/NFKB1/RELA/MAP2K1",5
"R-HSA-111458","R-HSA-111458","Formation of apoptosome","2/47","10/2914",0.0105533981968962,0.0350149171963243,0.0189070988957986,"MAPK3/MAPK1",2
"R-HSA-113501","R-HSA-113501","Inhibition of replication initiation of damaged DNA by RB1/E2F1","2/47","10/2914",0.0105533981968962,0.0350149171963243,0.0189070988957986,"RB1/E2F1",2
"R-HSA-1221632","R-HSA-1221632","Meiotic synapsis","2/47","10/2914",0.0105533981968962,0.0350149171963243,0.0189070988957986,"BRCA1/ATR",2
"R-HSA-1362300","R-HSA-1362300","Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1","2/47","10/2914",0.0105533981968962,0.0350149171963243,0.0189070988957986,"E2F1/CDK1",2
"R-HSA-209560","R-HSA-209560","NF-kB is activated and signals survival","2/47","10/2914",0.0105533981968962,0.0350149171963243,0.0189070988957986,"NFKB1/RELA",2
"R-HSA-74749","R-HSA-74749","Signal attenuation","2/47","10/2914",0.0105533981968962,0.0350149171963243,0.0189070988957986,"MAPK3/MAPK1",2
"R-HSA-8934903","R-HSA-8934903","Receptor Mediated Mitophagy","2/47","10/2914",0.0105533981968962,0.0350149171963243,0.0189070988957986,"CSNK2A1/CSNK2A2",2
"R-HSA-9020956","R-HSA-9020956","Interleukin-27 signaling","2/47","10/2914",0.0105533981968962,0.0350149171963243,0.0189070988957986,"STAT1/STAT3",2
"R-HSA-9020958","R-HSA-9020958","Interleukin-21 signaling","2/47","10/2914",0.0105533981968962,0.0350149171963243,0.0189070988957986,"STAT1/STAT3",2
"R-HSA-9627069","R-HSA-9627069","Regulation of the apoptosome activity","2/47","10/2914",0.0105533981968962,0.0350149171963243,0.0189070988957986,"MAPK3/MAPK1",2
"R-HSA-1912422","R-HSA-1912422","Pre-NOTCH Expression and Processing","3/47","29/2914",0.0107129616454713,0.03531048542356,0.0190666976654164,"EP300/E2F1/NOTCH1",3
"R-HSA-4420097","R-HSA-4420097","VEGFA-VEGFR2 Pathway","5/47","85/2914",0.0109859459671908,0.035973587774919,0.0194247548233095,"CTNNB1/MAPK14/AKT2/AKT1/AKT3",5
"R-HSA-390466","R-HSA-390466","Chaperonin-mediated protein folding","3/47","30/2914",0.0117701987209558,0.0382035748205068,0.0206288869185214,"CSNK2A1/STAT3/CSNK2A2",3
"R-HSA-68877","R-HSA-68877","Mitotic Prometaphase","4/47","56/2914",0.0118194692558454,0.0382035748205068,0.0206288869185214,"CSNK2A1/CSNK2A2/CDK1/PLK1",4
"R-HSA-1059683","R-HSA-1059683","Interleukin-6 signaling","2/47","11/2914",0.012766840068662,0.0393641527763186,0.0212555673148731,"STAT1/STAT3",2
"R-HSA-1362277","R-HSA-1362277","Transcription of E2F targets under negative control by DREAM complex","2/47","11/2914",0.012766840068662,0.0393641527763186,0.0212555673148731,"MAX/E2F1",2
"R-HSA-193692","R-HSA-193692","Regulated proteolysis of p75NTR","2/47","11/2914",0.012766840068662,0.0393641527763186,0.0212555673148731,"NFKB1/RELA",2
"R-HSA-452723","R-HSA-452723","Transcriptional regulation of pluripotent stem cells","2/47","11/2914",0.012766840068662,0.0393641527763186,0.0212555673148731,"STAT3/SMAD4",2
"R-HSA-6804116","R-HSA-6804116","TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest","2/47","11/2914",0.012766840068662,0.0393641527763186,0.0212555673148731,"CDK2/E2F1",2
"R-HSA-8866910","R-HSA-8866910","TFAP2 (AP-2) family regulates transcription of growth factors and their receptors","2/47","11/2914",0.012766840068662,0.0393641527763186,0.0212555673148731,"ESR1/YY1",2
"R-HSA-8984722","R-HSA-8984722","Interleukin-35 Signalling","2/47","11/2914",0.012766840068662,0.0393641527763186,0.0212555673148731,"STAT1/STAT3",2
"R-HSA-389356","R-HSA-389356","CD28 co-stimulation","3/47","31/2914",0.0128856707690943,0.0393641527763186,0.0212555673148731,"AKT2/AKT1/AKT3",3
"R-HSA-391251","R-HSA-391251","Protein folding","3/47","31/2914",0.0128856707690943,0.0393641527763186,0.0212555673148731,"CSNK2A1/STAT3/CSNK2A2",3
"R-HSA-3371453","R-HSA-3371453","Regulation of HSF1-mediated heat shock response","3/47","32/2914",0.0140598736406795,0.0419175223029871,0.0226343171170663,"MAPK3/MAPK1/ATR",3
"R-HSA-375165","R-HSA-375165","NCAM signaling for neurite out-growth","3/47","32/2914",0.0140598736406795,0.0419175223029871,0.0226343171170663,"MAPK3/MAPK1/RPS6KA5",3
"R-HSA-6802948","R-HSA-6802948","Signaling by high-kinase activity BRAF mutants","3/47","32/2914",0.0140598736406795,0.0419175223029871,0.0226343171170663,"MAPK3/MAPK1/MAP2K1",3
"R-HSA-8943724","R-HSA-8943724","Regulation of PTEN gene transcription","3/47","32/2914",0.0140598736406795,0.0419175223029871,0.0226343171170663,"MAPK3/MAPK1/LAMTOR3",3
"R-HSA-5693567","R-HSA-5693567","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","4/47","59/2914",0.0141398428527042,0.0419175223029871,0.0226343171170663,"CDK2/ABL1/BRCA1/ATR",4
"R-HSA-168249","R-HSA-168249","Innate Immune System","13/47","428/2914",0.0148063663970051,0.0429215021926806,0.0231764388350014,"CTNNB1/MAPK3/MAPK14/NFKB1/MAPK1/RELA/EP300/ABL1/RPS6KA5/DUSP7/MAP2K1/LAMTOR3/RPS6KA2",13
"R-HSA-194138","R-HSA-194138","Signaling by VEGF","5/47","92/2914",0.0151440770146953,0.0429215021926806,0.0231764388350014,"CTNNB1/MAPK14/AKT2/AKT1/AKT3",5
"R-HSA-111461","R-HSA-111461","Cytochrome c-mediated apoptotic response","2/47","12/2914",0.0151638840081925,0.0429215021926806,0.0231764388350014,"MAPK3/MAPK1",2
"R-HSA-1483206","R-HSA-1483206","Glycerophospholipid biosynthesis","2/47","12/2914",0.0151638840081925,0.0429215021926806,0.0231764388350014,"CSNK2A1/CSNK2A2",2
"R-HSA-1502540","R-HSA-1502540","Signaling by Activin","2/47","12/2914",0.0151638840081925,0.0429215021926806,0.0231764388350014,"SMAD3/SMAD4",2
"R-HSA-1839117","R-HSA-1839117","Signaling by cytosolic FGFR1 fusion mutants","2/47","12/2914",0.0151638840081925,0.0429215021926806,0.0231764388350014,"STAT1/STAT3",2
"R-HSA-210744","R-HSA-210744","Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells","2/47","12/2914",0.0151638840081925,0.0429215021926806,0.0231764388350014,"EP300/NOTCH1",2
"R-HSA-844456","R-HSA-844456","The NLRP3 inflammasome","2/47","12/2914",0.0151638840081925,0.0429215021926806,0.0231764388350014,"NFKB1/RELA",2
"R-HSA-176408","R-HSA-176408","Regulation of APC/C activators between G1/S and early anaphase","3/47","34/2914",0.0165861159641107,0.0465726310856132,0.0251479487110045,"CDK2/CDK1/PLK1",3
"R-HSA-69481","R-HSA-69481","G2/M Checkpoints","4/47","62/2914",0.0167326818271664,0.0465726310856132,0.0251479487110045,"CDK2/BRCA1/CDK1/ATR",4
"R-HSA-983231","R-HSA-983231","Factors involved in megakaryocyte development and platelet production","4/47","62/2914",0.0167326818271664,0.0465726310856132,0.0251479487110045,"CDK2/GATA2/ABL1/CDK5",4
"R-HSA-5693538","R-HSA-5693538","Homology Directed Repair","4/47","63/2914",0.0176591787169182,0.0475234456222884,0.0256613625904573,"CDK2/ABL1/BRCA1/ATR",4
"R-HSA-193639","R-HSA-193639","p75NTR signals via NF-kB","2/47","13/2914",0.0177382920785787,0.0475234456222884,0.0256613625904573,"NFKB1/RELA",2
"R-HSA-5626467","R-HSA-5626467","RHO GTPases activate IQGAPs","2/47","13/2914",0.0177382920785787,0.0475234456222884,0.0256613625904573,"CTNNB1/MEN1",2
"R-HSA-5689901","R-HSA-5689901","Metalloprotease DUBs","2/47","13/2914",0.0177382920785787,0.0475234456222884,0.0256613625904573,"EP300/BRCA1",2
"R-HSA-8941856","R-HSA-8941856","RUNX3 regulates NOTCH signaling","2/47","13/2914",0.0177382920785787,0.0475234456222884,0.0256613625904573,"EP300/NOTCH1",2
"R-HSA-912446","R-HSA-912446","Meiotic recombination","2/47","13/2914",0.0177382920785787,0.0475234456222884,0.0256613625904573,"CDK2/BRCA1",2
"R-HSA-9614657","R-HSA-9614657","FOXO-mediated transcription of cell death genes","2/47","13/2914",0.0177382920785787,0.0475234456222884,0.0256613625904573,"STK11/EP300",2
"R-HSA-195721","R-HSA-195721","Signaling by WNT","7/47","172/2914",0.0186981930651797,0.049828695349229,0.0269061344778902,"CSNK2A1/CTNNB1/MEN1/CSNK2A2/AKT2/EP300/AKT1",7
"R-HSA-2173793","R-HSA-2173793","Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer","3/47","36/2914",0.01935157006512,0.0512970190615086,0.0276989891770306,"SMAD3/MEN1/SMAD4",3
"R-HSA-1295596","R-HSA-1295596","Spry regulation of FGF signaling","2/47","14/2914",0.0204839723852919,0.053450365442871,0.028861737406908,"MAPK3/MAPK1",2
"R-HSA-5684264","R-HSA-5684264","MAP3K8 (TPL2)-dependent MAPK1/3 activation","2/47","14/2914",0.0204839723852919,0.053450365442871,0.028861737406908,"NFKB1/MAP2K1",2
"R-HSA-9617828","R-HSA-9617828","FOXO-mediated transcription of cell cycle genes","2/47","14/2914",0.0204839723852919,0.053450365442871,0.028861737406908,"SMAD3/SMAD4",2
"R-HSA-69275","R-HSA-69275","G2/M Transition","4/47","66/2914",0.0206297775889388,0.0535519096997841,0.0289165685320822,"CDK2/EP300/CDK1/PLK1",4
"R-HSA-9012852","R-HSA-9012852","Signaling by NOTCH3","3/47","37/2914",0.0208245587824102,0.0537788863401419,0.0290391297182823,"STAT1/EP300/NOTCH1",3
"R-HSA-1181150","R-HSA-1181150","Signaling by NODAL","2/47","15/2914",0.0233949761481387,0.0588989098000878,0.0318038025393898,"SMAD3/SMAD4",2
"R-HSA-176412","R-HSA-176412","Phosphorylation of the APC/C","2/47","15/2914",0.0233949761481387,0.0588989098000878,0.0318038025393898,"CDK1/PLK1",2
"R-HSA-6804114","R-HSA-6804114","TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest","2/47","15/2914",0.0233949761481387,0.0588989098000878,0.0318038025393898,"EP300/CDK1",2
"R-HSA-69205","R-HSA-69205","G1/S-Specific Transcription","2/47","15/2914",0.0233949761481387,0.0588989098000878,0.0318038025393898,"E2F1/CDK1",2
"R-HSA-9008059","R-HSA-9008059","Interleukin-37 signaling","2/47","15/2914",0.0233949761481387,0.0588989098000878,0.0318038025393898,"STAT3/SMAD3",2
"R-HSA-174143","R-HSA-174143","APC/C-mediated degradation of cell cycle proteins","3/47","40/2914",0.0256058804119357,0.062885029835195,0.0339561984822883,"CDK2/CDK1/PLK1",3
"R-HSA-381340","R-HSA-381340","Transcriptional regulation of white adipocyte differentiation","3/47","40/2914",0.0256058804119357,0.062885029835195,0.0339561984822883,"NFKB1/RELA/EP300",3
"R-HSA-453276","R-HSA-453276","Regulation of mitotic cell cycle","3/47","40/2914",0.0256058804119357,0.062885029835195,0.0339561984822883,"CDK2/CDK1/PLK1",3
"R-HSA-69231","R-HSA-69231","Cyclin D associated events in G1","3/47","40/2914",0.0256058804119357,0.062885029835195,0.0339561984822883,"RB1/ABL1/E2F1",3
"R-HSA-69236","R-HSA-69236","G1 Phase","3/47","40/2914",0.0256058804119357,0.062885029835195,0.0339561984822883,"RB1/ABL1/E2F1",3
"R-HSA-111471","R-HSA-111471","Apoptotic factor-mediated response","2/47","16/2914",0.0264654948266847,0.0631391090865193,0.0340933943381352,"MAPK3/MAPK1",2
"R-HSA-176187","R-HSA-176187","Activation of ATR in response to replication stress","2/47","16/2914",0.0264654948266847,0.0631391090865193,0.0340933943381352,"CDK2/ATR",2
"R-HSA-1810476","R-HSA-1810476","RIP-mediated NFkB activation via ZBP1","2/47","16/2914",0.0264654948266847,0.0631391090865193,0.0340933943381352,"NFKB1/RELA",2
"R-HSA-5205647","R-HSA-5205647","Mitophagy","2/47","16/2914",0.0264654948266847,0.0631391090865193,0.0340933943381352,"CSNK2A1/CSNK2A2",2
"R-HSA-622312","R-HSA-622312","Inflammasomes","2/47","16/2914",0.0264654948266847,0.0631391090865193,0.0340933943381352,"NFKB1/RELA",2
"R-HSA-8852276","R-HSA-8852276","The role of GTSE1 in G2/M progression after G2 checkpoint","2/47","16/2914",0.0264654948266847,0.0631391090865193,0.0340933943381352,"CDK1/PLK1",2
"R-HSA-194315","R-HSA-194315","Signaling by Rho GTPases","8/47","228/2914",0.0271021420276054,0.0643515315442195,0.0347480693494368,"CTNNB1/MAPK3/MEN1/MAPK14/AR/MAPK1/ABL1/PLK1",8
"R-HSA-3108232","R-HSA-3108232","SUMO E3 ligases SUMOylate target proteins","5/47","107/2914",0.0273569985422425,0.0645772281949691,0.0348699393762098,"AR/RELA/ESR1/EP300/BRCA1",5
"R-HSA-5621481","R-HSA-5621481","C-type lectin receptors (CLRs)","4/47","72/2914",0.0274549892325916,0.0645772281949691,0.0348699393762098,"NFKB1/RELA/EP300/RPS6KA5",4
"R-HSA-6802946","R-HSA-6802946","Signaling by moderate kinase activity BRAF mutants","3/47","42/2914",0.0290954304231946,0.0671742425899562,0.0362722562151881,"MAPK3/MAPK1/MAP2K1",3
"R-HSA-6802949","R-HSA-6802949","Signaling by RAS mutants","3/47","42/2914",0.0290954304231946,0.0671742425899562,0.0362722562151881,"MAPK3/MAPK1/MAP2K1",3
"R-HSA-6802955","R-HSA-6802955","Paradoxical activation of RAF signaling by kinase inactive BRAF","3/47","42/2914",0.0290954304231946,0.0671742425899562,0.0362722562151881,"MAPK3/MAPK1/MAP2K1",3
"R-HSA-9649948","R-HSA-9649948","Signaling downstream of RAS mutants","3/47","42/2914",0.0290954304231946,0.0671742425899562,0.0362722562151881,"MAPK3/MAPK1/MAP2K1",3
"R-HSA-2990846","R-HSA-2990846","SUMOylation","5/47","109/2914",0.029354067964673,0.0674604956435833,0.0364268250454899,"AR/RELA/ESR1/EP300/BRCA1",5
"R-HSA-2029482","R-HSA-2029482","Regulation of actin dynamics for phagocytic cup formation","3/47","43/2914",0.0309305614810185,0.0707589557168504,0.0382079033915969,"MAPK3/MAPK1/ABL1",3
"R-HSA-1227986","R-HSA-1227986","Signaling by ERBB2","3/47","44/2914",0.0328257145807299,0.0747531045679348,0.0403646346758257,"AKT2/AKT1/AKT3",3
"R-HSA-380972","R-HSA-380972","Energy dependent regulation of mTOR by LKB1-AMPK","2/47","18/2914",0.0330625270874696,0.0749517016779288,0.040471871690782,"STK11/LAMTOR3",2
"R-HSA-69620","R-HSA-69620","Cell Cycle Checkpoints","5/47","114/2914",0.0347476603898748,0.0784170173663392,0.0423430475116066,"CDK2/BRCA1/CDK1/ATR/PLK1",5
"R-HSA-1606322","R-HSA-1606322","ZBP1(DAI) mediated induction of type I IFNs","2/47","19/2914",0.0365780996468611,0.0808525822570769,0.0436581860280886,"NFKB1/RELA",2
"R-HSA-2980766","R-HSA-2980766","Nuclear Envelope Breakdown","2/47","19/2914",0.0365780996468611,0.0808525822570769,0.0436581860280886,"CDK1/PLK1",2
"R-HSA-6814122","R-HSA-6814122","Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding","2/47","19/2914",0.0365780996468611,0.0808525822570769,0.0436581860280886,"CSNK2A1/CSNK2A2",2
"R-HSA-9615017","R-HSA-9615017","FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes","2/47","19/2914",0.0365780996468611,0.0808525822570769,0.0436581860280886,"SMAD3/SMAD4",2
"R-HSA-6802952","R-HSA-6802952","Signaling by BRAF and RAF fusions","3/47","46/2914",0.0367951871349572,0.0808525822570769,0.0436581860280886,"MAPK3/MAPK1/MAP2K1",3
"R-HSA-69473","R-HSA-69473","G2/M DNA damage checkpoint","3/47","46/2914",0.0367951871349572,0.0808525822570769,0.0436581860280886,"BRCA1/CDK1/ATR",3
"R-HSA-73894","R-HSA-73894","DNA Repair","6/47","157/2914",0.0382258316932911,0.083629439643401,0.0451576131701945,"CDK2/EP300/ABL1/BRCA1/YY1/ATR",6
"R-HSA-438064","R-HSA-438064","Post NMDA receptor activation events","3/47","47/2914",0.0388689572409296,0.0839368430073523,0.0453236025903762,"MAPK3/MAPK1/RPS6KA2",3
"R-HSA-8848021","R-HSA-8848021","Signaling by PTK6","3/47","47/2914",0.0388689572409296,0.0839368430073523,0.0453236025903762,"STAT3/CDK2/AKT1",3
"R-HSA-9006927","R-HSA-9006927","Signaling by Non-Receptor Tyrosine Kinases","3/47","47/2914",0.0388689572409296,0.0839368430073523,0.0453236025903762,"STAT3/CDK2/AKT1",3
"R-HSA-5693532","R-HSA-5693532","DNA Double-Strand Break Repair","4/47","81/2914",0.0399809581749163,0.0854062760304295,0.0461170562870478,"CDK2/ABL1/BRCA1/ATR",4
"R-HSA-2173795","R-HSA-2173795","Downregulation of SMAD2/3:SMAD4 transcriptional activity","2/47","20/2914",0.0402312996869887,0.0854062760304295,0.0461170562870478,"SMAD3/SMAD4",2
"R-HSA-5260271","R-HSA-5260271","Diseases of Immune System","2/47","20/2914",0.0402312996869887,0.0854062760304295,0.0461170562870478,"NFKB1/RELA",2
"R-HSA-5602358","R-HSA-5602358","Diseases associated with the TLR signaling cascade","2/47","20/2914",0.0402312996869887,0.0854062760304295,0.0461170562870478,"NFKB1/RELA",2
"R-HSA-168643","R-HSA-168643","Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways","3/47","48/2914",0.0410016541477275,0.086310204739544,0.0466051531002475,"MAPK14/NFKB1/RELA",3
"R-HSA-5693607","R-HSA-5693607","Processing of DNA double-strand break ends","3/47","48/2914",0.0410016541477275,0.086310204739544,0.0466051531002475,"CDK2/BRCA1/ATR",3
"R-HSA-442755","R-HSA-442755","Activation of NMDA receptors and postsynaptic events","3/47","49/2914",0.0431929114083181,0.0897910730936405,0.0484847269357403,"MAPK3/MAPK1/RPS6KA2",3
"R-HSA-6802957","R-HSA-6802957","Oncogenic MAPK signaling","3/47","49/2914",0.0431929114083181,0.0897910730936405,0.0484847269357403,"MAPK3/MAPK1/MAP2K1",3
"R-HSA-9018519","R-HSA-9018519","Estrogen-dependent gene expression","3/47","49/2914",0.0431929114083181,0.0897910730936405,0.0484847269357403,"ESR1/EP300/YY1",3
"R-HSA-597592","R-HSA-597592","Post-translational protein modification","11/47","393/2914",0.043732257420728,0.0905366155693583,0.0488872995090347,"SMAD3/MEN1/SMAD4/AR/RELA/FBXO22/ESR1/EP300/BRCA1/YY1/CDK1",11
"R-HSA-933542","R-HSA-933542","TRAF6 mediated NF-kB activation","2/47","21/2914",0.0440169785559094,0.0907510545535417,0.0490030907033516,"NFKB1/RELA",2
"R-HSA-2454202","R-HSA-2454202","Fc epsilon receptor (FCERI) signaling","4/47","87/2914",0.0498892671116208,0.102061202047781,0.0551102614272084,"MAPK3/NFKB1/MAPK1/RELA",4
"R-HSA-74751","R-HSA-74751","Insulin receptor signalling cascade","3/47","52/2914",0.050113883640228,0.102061202047781,0.0551102614272084,"MAPK3/AKT2/MAPK1",3
"R-HSA-74752","R-HSA-74752","Signaling by Insulin receptor","3/47","52/2914",0.050113883640228,0.102061202047781,0.0551102614272084,"MAPK3/AKT2/MAPK1",3
"R-HSA-5693616","R-HSA-5693616","Presynaptic phase of homologous DNA pairing and strand exchange","2/47","23/2914",0.0519657959725957,0.104557685872572,0.0564582945041518,"BRCA1/ATR",2
"R-HSA-6783589","R-HSA-6783589","Interleukin-6 family signaling","2/47","23/2914",0.0519657959725957,0.104557685872572,0.0564582945041518,"STAT1/STAT3",2
"R-HSA-69002","R-HSA-69002","DNA Replication Pre-Initiation","2/47","23/2914",0.0519657959725957,0.104557685872572,0.0564582945041518,"CDK2/E2F1",2
"R-HSA-1632852","R-HSA-1632852","Macroautophagy","3/47","53/2914",0.05253506562756,0.104860828204811,0.0566219830835938,"CSNK2A1/CSNK2A2/LAMTOR3",3
"R-HSA-388841","R-HSA-388841","Costimulation by the CD28 family","3/47","53/2914",0.05253506562756,0.104860828204811,0.0566219830835938,"AKT2/AKT1/AKT3",3
"R-HSA-1169091","R-HSA-1169091","Activation of NF-kappaB in B cells","2/47","24/2914",0.0561192474881611,0.109827121060815,0.0593036455775387,"NFKB1/RELA",2
"R-HSA-1839124","R-HSA-1839124","FGFR1 mutant receptor activation","2/47","24/2914",0.0561192474881611,0.109827121060815,0.0593036455775387,"STAT1/STAT3",2
"R-HSA-2559586","R-HSA-2559586","DNA Damage/Telomere Stress Induced Senescence","2/47","24/2914",0.0561192474881611,0.109827121060815,0.0593036455775387,"RB1/CDK2",2
"R-HSA-5693579","R-HSA-5693579","Homologous DNA Pairing and Strand Exchange","2/47","24/2914",0.0561192474881611,0.109827121060815,0.0593036455775387,"BRCA1/ATR",2
"R-HSA-8854691","R-HSA-8854691","Interleukin-20 family signaling","2/47","24/2914",0.0561192474881611,0.109827121060815,0.0593036455775387,"STAT1/STAT3",2
"R-HSA-6811558","R-HSA-6811558","PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling","4/47","92/2914",0.0590998730970723,0.115210258449935,0.0622103927337603,"MAPK3/MAPK1/ESR1/AKT1",4
"R-HSA-380259","R-HSA-380259","Loss of Nlp from mitotic centrosomes","2/47","25/2914",0.060385798856941,0.116358789335875,0.0628305680414326,"CDK1/PLK1",2
"R-HSA-380284","R-HSA-380284","Loss of proteins required for interphase microtubule organization from the centrosome","2/47","25/2914",0.060385798856941,0.116358789335875,0.0628305680414326,"CDK1/PLK1",2
"R-HSA-456926","R-HSA-456926","Thrombin signalling through proteinase activated receptors (PARs)","2/47","25/2914",0.060385798856941,0.116358789335875,0.0628305680414326,"MAPK3/MAPK1",2
"R-HSA-9020702","R-HSA-9020702","Interleukin-1 signaling","3/47","57/2914",0.0627767257892458,0.12050245065292,0.0650680319735276,"NFKB1/RELA/MAP2K1",3
"R-HSA-1445148","R-HSA-1445148","Translocation of SLC2A4 (GLUT4) to the plasma membrane","2/47","26/2914",0.0647608969635559,0.122434752372609,0.0661114221236698,"AKT2/AKT1",2
"R-HSA-380320","R-HSA-380320","Recruitment of NuMA to mitotic centrosomes","2/47","26/2914",0.0647608969635559,0.122434752372609,0.0661114221236698,"CDK1/PLK1",2
"R-HSA-8854518","R-HSA-8854518","AURKA Activation by TPX2","2/47","26/2914",0.0647608969635559,0.122434752372609,0.0661114221236698,"CDK1/PLK1",2
"R-HSA-8939902","R-HSA-8939902","Regulation of RUNX2 expression and activity","2/47","26/2914",0.0647608969635559,0.122434752372609,0.0661114221236698,"STAT1/ESR1",2
"R-HSA-2219528","R-HSA-2219528","PI3K/AKT Signaling in Cancer","4/47","97/2914",0.0691678307371369,0.127534155866535,0.0688649607263359,"AKT2/ESR1/AKT1/AKT3",4
"R-HSA-1251985","R-HSA-1251985","Nuclear signaling by ERBB4","2/47","27/2914",0.0692401005902147,0.127534155866535,0.0688649607263359,"ESR1/YAP1",2
"R-HSA-380270","R-HSA-380270","Recruitment of mitotic centrosome proteins and complexes","2/47","27/2914",0.0692401005902147,0.127534155866535,0.0688649607263359,"CDK1/PLK1",2
"R-HSA-380287","R-HSA-380287","Centrosome maturation","2/47","27/2914",0.0692401005902147,0.127534155866535,0.0688649607263359,"CDK1/PLK1",2
"R-HSA-445989","R-HSA-445989","TAK1 activates NFkB by phosphorylation and activation of IKKs complex","2/47","27/2914",0.0692401005902147,0.127534155866535,0.0688649607263359,"NFKB1/RELA",2
"R-HSA-5654732","R-HSA-5654732","Negative regulation of FGFR3 signaling","2/47","27/2914",0.0692401005902147,0.127534155866535,0.0688649607263359,"MAPK3/MAPK1",2
"R-HSA-5689896","R-HSA-5689896","Ovarian tumor domain proteases","2/47","27/2914",0.0692401005902147,0.127534155866535,0.0688649607263359,"ESR1/CDK1",2
"R-HSA-2173789","R-HSA-2173789","TGF-beta receptor signaling activates SMADs","2/47","28/2914",0.0738190781166333,0.133625371689367,0.0721540508964542,"SMAD3/SMAD4",2
"R-HSA-4090294","R-HSA-4090294","SUMOylation of intracellular receptors","2/47","28/2914",0.0738190781166333,0.133625371689367,0.0721540508964542,"AR/ESR1",2
"R-HSA-5620912","R-HSA-5620912","Anchoring of the basal body to the plasma membrane","2/47","28/2914",0.0738190781166333,0.133625371689367,0.0721540508964542,"CDK1/PLK1",2
"R-HSA-5654733","R-HSA-5654733","Negative regulation of FGFR4 signaling","2/47","28/2914",0.0738190781166333,0.133625371689367,0.0721540508964542,"MAPK3/MAPK1",2
"R-HSA-9612973","R-HSA-9612973","Autophagy","3/47","61/2914",0.0738806945268557,0.133625371689367,0.0721540508964542,"CSNK2A1/CSNK2A2/LAMTOR3",3
"R-HSA-2029480","R-HSA-2029480","Fcgamma receptor (FCGR) dependent phagocytosis","3/47","62/2914",0.0767865256810771,0.138381472540358,0.0747222154488331,"MAPK3/MAPK1/ABL1",3
"R-HSA-186763","R-HSA-186763","Downstream signal transduction","2/47","29/2914",0.0784936052626453,0.140950882568406,0.076109626683644,"STAT1/STAT3",2
"R-HSA-170834","R-HSA-170834","Signaling by TGF-beta Receptor Complex","3/47","63/2914",0.0797428930292851,0.142682819313114,0.0770448252200235,"SMAD3/MEN1/SMAD4",3
"R-HSA-1483257","R-HSA-1483257","Phospholipid metabolism","2/47","30/2914",0.083259562872766,0.146876904926957,0.0793095168951107,"CSNK2A1/CSNK2A2",2
"R-HSA-176814","R-HSA-176814","Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins","2/47","30/2914",0.083259562872766,0.146876904926957,0.0793095168951107,"CDK1/PLK1",2
"R-HSA-2871796","R-HSA-2871796","FCERI mediated MAPK activation","2/47","30/2914",0.083259562872766,0.146876904926957,0.0793095168951107,"MAPK3/MAPK1",2
"R-HSA-5654726","R-HSA-5654726","Negative regulation of FGFR1 signaling","2/47","30/2914",0.083259562872766,0.146876904926957,0.0793095168951107,"MAPK3/MAPK1",2
"R-HSA-3214841","R-HSA-3214841","PKMTs methylate histone lysines","2/47","31/2914",0.0881129347419847,0.153813868661095,0.0830552878367507,"NFKB1/RELA",2
"R-HSA-450531","R-HSA-450531","Regulation of mRNA stability by proteins that bind AU-rich elements","2/47","31/2914",0.0881129347419847,0.153813868661095,0.0830552878367507,"MAPK14/AKT1",2
"R-HSA-5655302","R-HSA-5655302","Signaling by FGFR1 in disease","2/47","31/2914",0.0881129347419847,0.153813868661095,0.0830552878367507,"STAT1/STAT3",2
"R-HSA-168928","R-HSA-168928","DDX58/IFIH1-mediated induction of interferon-alpha/beta","3/47","66/2914",0.0889078579374577,0.154662627870369,0.0835135946269248,"NFKB1/RELA/EP300",3
"R-HSA-447115","R-HSA-447115","Interleukin-12 family signaling","2/47","32/2914",0.0930498054820717,0.160751560505234,0.0868014519379035,"STAT1/STAT3",2
"R-HSA-5654727","R-HSA-5654727","Negative regulation of FGFR2 signaling","2/47","32/2914",0.0930498054820717,0.160751560505234,0.0868014519379035,"MAPK3/MAPK1",2
"R-HSA-3247509","R-HSA-3247509","Chromatin modifying enzymes","4/47","109/2914",0.0967145701528833,0.165938354954091,0.0896021792692538,"KDM6A/NFKB1/RELA/EP300",4
"R-HSA-4839726","R-HSA-4839726","Chromatin organization","4/47","109/2914",0.0967145701528833,0.165938354954091,0.0896021792692538,"KDM6A/NFKB1/RELA/EP300",4
"R-HSA-5685942","R-HSA-5685942","HDR through Homologous Recombination (HRR)","2/47","33/2914",0.0980663584276971,0.167683431987291,0.0905444732025082,"BRCA1/ATR",2
"R-HSA-109582","R-HSA-109582","Hemostasis","8/47","298/2914",0.100668585217756,0.171547487054747,0.0926309573969323,"MAPK3/MAPK14/MAPK1/CDK2/GATA2/ABL1/AKT1/CDK5",8
"R-HSA-1169408","R-HSA-1169408","ISG15 antiviral mechanism","2/47","34/2914",0.103158873581671,0.173431529075226,0.0936482886276563,"STAT1/MAPK3",2
"R-HSA-2500257","R-HSA-2500257","Resolution of Sister Chromatid Cohesion","2/47","34/2914",0.103158873581671,0.173431529075226,0.0936482886276563,"CDK1/PLK1",2
"R-HSA-5693565","R-HSA-5693565","Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks","2/47","34/2914",0.103158873581671,0.173431529075226,0.0936482886276563,"ABL1/BRCA1",2
"R-HSA-6796648","R-HSA-6796648","TP53 Regulates Transcription of DNA Repair Genes","2/47","34/2914",0.103158873581671,0.173431529075226,0.0936482886276563,"BRCA1/ATR",2
"R-HSA-1169410","R-HSA-1169410","Antiviral mechanism by IFN-stimulated genes","2/47","35/2914",0.108323725598628,0.180900621749709,0.0976813946626224,"STAT1/MAPK3",2
"R-HSA-5693606","R-HSA-5693606","DNA Double Strand Break Response","2/47","35/2914",0.108323725598628,0.180900621749709,0.0976813946626224,"ABL1/BRCA1",2
"R-HSA-2565942","R-HSA-2565942","Regulation of PLK1 Activity at G2/M Transition","2/47","37/2914",0.118856400265,0.197175683883327,0.106469483681091,"CDK1/PLK1",2
"R-HSA-5654741","R-HSA-5654741","Signaling by FGFR3","2/47","37/2914",0.118856400265,0.197175683883327,0.106469483681091,"MAPK3/MAPK1",2
"R-HSA-2871837","R-HSA-2871837","FCERI mediated NF-kB activation","2/47","38/2914",0.12421742786085,0.204713589994361,0.110539747092238,"NFKB1/RELA",2
"R-HSA-5654743","R-HSA-5654743","Signaling by FGFR4","2/47","38/2914",0.12421742786085,0.204713589994361,0.110539747092238,"MAPK3/MAPK1",2
"R-HSA-112314","R-HSA-112314","Neurotransmitter receptors and postsynaptic signal transmission","3/47","77/2914",0.126007962672116,0.206983571471246,0.111765475087951,"MAPK3/MAPK1/RPS6KA2",3
"R-HSA-1168372","R-HSA-1168372","Downstream signaling events of B Cell Receptor (BCR)","2/47","39/2914",0.129637198438476,0.212249138619858,0.114608737525588,"NFKB1/RELA",2
"R-HSA-2122947","R-HSA-2122947","NOTCH1 Intracellular Domain Regulates Transcription","2/47","40/2914",0.135112530966189,0.220493087993683,0.119060245013923,"EP300/NOTCH1",2
"R-HSA-1852241","R-HSA-1852241","Organelle biogenesis and maintenance","3/47","80/2914",0.136981457082812,0.222096148862424,0.119925854097369,"MAPK14/CDK1/PLK1",3
"R-HSA-5689880","R-HSA-5689880","Ub-specific processing proteases","3/47","80/2914",0.136981457082812,0.222096148862424,0.119925854097369,"SMAD3/SMAD4/AR",3
"R-HSA-6798695","R-HSA-6798695","Neutrophil degranulation","4/47","125/2914",0.140275579109446,0.225114390403068,0.121555622089691,"MAPK14/NFKB1/MAPK1/LAMTOR3",4
"R-HSA-1433557","R-HSA-1433557","Signaling by SCF-KIT","2/47","41/2914",0.140640327736847,0.225114390403068,0.121555622089691,"STAT1/STAT3",2
"R-HSA-451927","R-HSA-451927","Interleukin-2 family signaling","2/47","41/2914",0.140640327736847,0.225114390403068,0.121555622089691,"STAT1/STAT3",2
"R-HSA-5654736","R-HSA-5654736","Signaling by FGFR1","2/47","41/2914",0.140640327736847,0.225114390403068,0.121555622089691,"MAPK3/MAPK1",2
"R-HSA-5617833","R-HSA-5617833","Cilium Assembly","2/47","42/2914",0.146217572602529,0.233296190681106,0.125973570763828,"CDK1/PLK1",2
"R-HSA-4755510","R-HSA-4755510","SUMOylation of immune response proteins","1/47","10/2914",0.150288945927503,0.237522908232425,0.128255882793851,"RELA",1
"R-HSA-5250924","R-HSA-5250924","B-WICH complex positively regulates rRNA expression","1/47","10/2914",0.150288945927503,0.237522908232425,0.128255882793851,"EP300",1
"R-HSA-9617629","R-HSA-9617629","Regulation of FOXO transcriptional activity by acetylation","1/47","10/2914",0.150288945927503,0.237522908232425,0.128255882793851,"EP300",1
"R-HSA-202424","R-HSA-202424","Downstream TCR signaling","2/47","43/2914",0.151841329242603,0.23922171682561,0.129173193033264,"NFKB1/RELA",2
"R-HSA-1236394","R-HSA-1236394","Signaling by ERBB4","2/47","44/2914",0.157508739464597,0.247372659786091,0.133574479598751,"ESR1/YAP1",2
"R-HSA-9006936","R-HSA-9006936","Signaling by TGF-beta family members","3/47","86/2914",0.15987447093639,0.250303468559785,0.13515703628504,"SMAD3/MEN1/SMAD4",3
"R-HSA-1226099","R-HSA-1226099","Signaling by FGFR in disease","2/47","45/2914",0.163217021537313,0.252100059549714,0.136127146347886,"STAT1/STAT3",2
"R-HSA-2197563","R-HSA-2197563","NOTCH2 intracellular domain regulates transcription","1/47","11/2914",0.164041156513387,0.252100059549714,0.136127146347886,"EP300",1
"R-HSA-2586552","R-HSA-2586552","Signaling by Leptin","1/47","11/2914",0.164041156513387,0.252100059549714,0.136127146347886,"STAT3",1
"R-HSA-3371568","R-HSA-3371568","Attenuation phase","1/47","11/2914",0.164041156513387,0.252100059549714,0.136127146347886,"EP300",1
"R-HSA-5210891","R-HSA-5210891","Uptake and function of anthrax toxins","1/47","11/2914",0.164041156513387,0.252100059549714,0.136127146347886,"MAP2K1",1
"R-HSA-75035","R-HSA-75035","Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex","1/47","11/2914",0.164041156513387,0.252100059549714,0.136127146347886,"CDK1",1
"R-HSA-112315","R-HSA-112315","Transmission across Chemical Synapses","3/47","88/2914",0.167760406094712,0.257027411172632,0.138787781639597,"MAPK3/MAPK1/RPS6KA2",3
"R-HSA-383280","R-HSA-383280","Nuclear Receptor transcription pathway","2/47","46/2914",0.168963468555602,0.25808139556816,0.13935690442487,"AR/ESR1",2
"R-HSA-2032785","R-HSA-2032785","YAP1- and WWTR1 (TAZ)-stimulated gene expression","1/47","12/2914",0.177575454013859,0.264777685895665,0.142972718300632,"YAP1",1
"R-HSA-2691230","R-HSA-2691230","Signaling by NOTCH1 HD Domain Mutants in Cancer","1/47","12/2914",0.177575454013859,0.264777685895665,0.142972718300632,"NOTCH1",1
"R-HSA-2691232","R-HSA-2691232","Constitutive Signaling by NOTCH1 HD Domain Mutants","1/47","12/2914",0.177575454013859,0.264777685895665,0.142972718300632,"NOTCH1",1
"R-HSA-3301854","R-HSA-3301854","Nuclear Pore Complex (NPC) Disassembly","1/47","12/2914",0.177575454013859,0.264777685895665,0.142972718300632,"CDK1",1
"R-HSA-381771","R-HSA-381771","Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)","1/47","12/2914",0.177575454013859,0.264777685895665,0.142972718300632,"CTNNB1",1
"R-HSA-418990","R-HSA-418990","Adherens junctions interactions","1/47","12/2914",0.177575454013859,0.264777685895665,0.142972718300632,"CTNNB1",1
"R-HSA-68962","R-HSA-68962","Activation of the pre-replicative complex","1/47","12/2914",0.177575454013859,0.264777685895665,0.142972718300632,"CDK2",1
"R-HSA-9639288","R-HSA-9639288","Amino acids regulate mTORC1","1/47","12/2914",0.177575454013859,0.264777685895665,0.142972718300632,"LAMTOR3",1
"R-HSA-186797","R-HSA-186797","Signaling by PDGF","2/47","49/2914",0.186405819150243,0.277119630250065,0.149637031146689,"STAT1/STAT3",2
"R-HSA-1368082","R-HSA-1368082","RORA activates gene expression","1/47","13/2914",0.190895217508466,0.2804648210315,0.151443342798814,"EP300",1
"R-HSA-171007","R-HSA-171007","p38MAPK events","1/47","13/2914",0.190895217508466,0.2804648210315,0.151443342798814,"MAPK14",1
"R-HSA-3906995","R-HSA-3906995","Diseases associated with O-glycosylation of proteins","1/47","13/2914",0.190895217508466,0.2804648210315,0.151443342798814,"NOTCH1",1
"R-HSA-6804760","R-HSA-6804760","Regulation of TP53 Activity through Methylation","1/47","13/2914",0.190895217508466,0.2804648210315,0.151443342798814,"EP300",1
"R-HSA-6785807","R-HSA-6785807","Interleukin-4 and Interleukin-13 signaling","3/47","94/2914",0.192086523250671,0.280851102784777,0.151651924394764,"STAT1/STAT3/AKT1",3
"R-HSA-5654738","R-HSA-5654738","Signaling by FGFR2","2/47","50/2914",0.192279297914528,0.280851102784777,0.151651924394764,"MAPK3/MAPK1",2
"R-HSA-2644602","R-HSA-2644602","Signaling by NOTCH1 PEST Domain Mutants in Cancer","2/47","51/2914",0.198178474403996,0.283118812154133,0.152876425514471,"EP300/NOTCH1",2
"R-HSA-2644603","R-HSA-2644603","Signaling by NOTCH1 in Cancer","2/47","51/2914",0.198178474403996,0.283118812154133,0.152876425514471,"EP300/NOTCH1",2
"R-HSA-2644606","R-HSA-2644606","Constitutive Signaling by NOTCH1 PEST Domain Mutants","2/47","51/2914",0.198178474403996,0.283118812154133,0.152876425514471,"EP300/NOTCH1",2
"R-HSA-2894858","R-HSA-2894858","Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer","2/47","51/2914",0.198178474403996,0.283118812154133,0.152876425514471,"EP300/NOTCH1",2
"R-HSA-2894862","R-HSA-2894862","Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants","2/47","51/2914",0.198178474403996,0.283118812154133,0.152876425514471,"EP300/NOTCH1",2
"R-HSA-69306","R-HSA-69306","DNA Replication","2/47","51/2914",0.198178474403996,0.283118812154133,0.152876425514471,"CDK2/E2F1",2
"R-HSA-400508","R-HSA-400508","Incretin synthesis, secretion, and inactivation","1/47","14/2914",0.204003774825633,0.283118812154133,0.152876425514471,"CTNNB1",1
"R-HSA-4839743","R-HSA-4839743","phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex","1/47","14/2914",0.204003774825633,0.283118812154133,0.152876425514471,"CTNNB1",1
"R-HSA-5339716","R-HSA-5339716","Misspliced GSK3beta mutants stabilize beta-catenin","1/47","14/2914",0.204003774825633,0.283118812154133,0.152876425514471,"CTNNB1",1
"R-HSA-5358747","R-HSA-5358747","S33 mutants of beta-catenin aren't phosphorylated","1/47","14/2914",0.204003774825633,0.283118812154133,0.152876425514471,"CTNNB1",1
"R-HSA-5358749","R-HSA-5358749","S37 mutants of beta-catenin aren't phosphorylated","1/47","14/2914",0.204003774825633,0.283118812154133,0.152876425514471,"CTNNB1",1
"R-HSA-5358751","R-HSA-5358751","S45 mutants of beta-catenin aren't phosphorylated","1/47","14/2914",0.204003774825633,0.283118812154133,0.152876425514471,"CTNNB1",1
"R-HSA-5358752","R-HSA-5358752","T41 mutants of beta-catenin aren't phosphorylated","1/47","14/2914",0.204003774825633,0.283118812154133,0.152876425514471,"CTNNB1",1
"R-HSA-5693554","R-HSA-5693554","Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)","1/47","14/2914",0.204003774825633,0.283118812154133,0.152876425514471,"BRCA1",1
"R-HSA-68867","R-HSA-68867","Assembly of the pre-replicative complex","1/47","14/2914",0.204003774825633,0.283118812154133,0.152876425514471,"E2F1",1
"R-HSA-877312","R-HSA-877312","Regulation of IFNG signaling","1/47","14/2914",0.204003774825633,0.283118812154133,0.152876425514471,"STAT1",1
"R-HSA-8983432","R-HSA-8983432","Interleukin-15 signaling","1/47","14/2914",0.204003774825633,0.283118812154133,0.152876425514471,"STAT3",1
"R-HSA-918233","R-HSA-918233","TRAF3-dependent IRF activation pathway","1/47","14/2914",0.204003774825633,0.283118812154133,0.152876425514471,"EP300",1
"R-HSA-5607764","R-HSA-5607764","CLEC7A (Dectin-1) signaling","2/47","53/2914",0.210044822442664,0.290697392386118,0.156968651839967,"NFKB1/RELA",2
"R-HSA-2028269","R-HSA-2028269","Signaling by Hippo","1/47","15/2914",0.216904403302597,0.291338085937268,0.157314608857817,"YAP1",1
"R-HSA-3214842","R-HSA-3214842","HDMs demethylate histones","1/47","15/2914",0.216904403302597,0.291338085937268,0.157314608857817,"KDM6A",1
"R-HSA-3371497","R-HSA-3371497","HSP90 chaperone cycle for steroid hormone receptors (SHR)","1/47","15/2914",0.216904403302597,0.291338085937268,0.157314608857817,"AR",1
"R-HSA-432142","R-HSA-432142","Platelet sensitization by LDL","1/47","15/2914",0.216904403302597,0.291338085937268,0.157314608857817,"MAPK14",1
"R-HSA-5250913","R-HSA-5250913","Positive epigenetic regulation of rRNA expression","1/47","15/2914",0.216904403302597,0.291338085937268,0.157314608857817,"EP300",1
"R-HSA-5693537","R-HSA-5693537","Resolution of D-Loop Structures","1/47","15/2914",0.216904403302597,0.291338085937268,0.157314608857817,"BRCA1",1
"R-HSA-5693568","R-HSA-5693568","Resolution of D-loop Structures through Holliday Junction Intermediates","1/47","15/2914",0.216904403302597,0.291338085937268,0.157314608857817,"BRCA1",1
"R-HSA-8862803","R-HSA-8862803","Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models","1/47","15/2914",0.216904403302597,0.291338085937268,0.157314608857817,"CDK5",1
"R-HSA-8863678","R-HSA-8863678","Neurodegenerative Diseases","1/47","15/2914",0.216904403302597,0.291338085937268,0.157314608857817,"CDK5",1
"R-HSA-8876384","R-HSA-8876384","Listeria monocytogenes entry into host cells","1/47","15/2914",0.216904403302597,0.291338085937268,0.157314608857817,"CTNNB1",1
"R-HSA-9604323","R-HSA-9604323","Negative regulation of NOTCH4 signaling","1/47","15/2914",0.216904403302597,0.291338085937268,0.157314608857817,"AKT1",1
"R-HSA-190236","R-HSA-190236","Signaling by FGFR","2/47","55/2914",0.221987300860466,0.296575033949582,0.16014241774355,"MAPK3/MAPK1",2
"R-HSA-5696398","R-HSA-5696398","Nucleotide Excision Repair","2/47","55/2914",0.221987300860466,0.296575033949582,0.16014241774355,"EP300/YY1",2
"R-HSA-166208","R-HSA-166208","mTORC1-mediated signalling","1/47","16/2914",0.229600330534324,0.304311549200255,0.164319924665334,"LAMTOR3",1
"R-HSA-196299","R-HSA-196299","Beta-catenin phosphorylation cascade","1/47","16/2914",0.229600330534324,0.304311549200255,0.164319924665334,"CTNNB1",1
"R-HSA-8941858","R-HSA-8941858","Regulation of RUNX3 expression and activity","1/47","16/2914",0.229600330534324,0.304311549200255,0.164319924665334,"EP300",1
"R-HSA-76002","R-HSA-76002","Platelet activation, signaling and aggregation","4/47","153/2914",0.231364506645098,0.305840680288111,0.165145613686405,"MAPK3/MAPK14/MAPK1/AKT1",4
"R-HSA-112316","R-HSA-112316","Neuronal System","3/47","105/2914",0.238789435897135,0.314825019432802,0.169996911428154,"MAPK3/MAPK1/RPS6KA2",3
"R-HSA-174048","R-HSA-174048","APC/C:Cdc20 mediated degradation of Cyclin B","1/47","17/2914",0.24209473511158,0.315037564391952,0.170111679900687,"CDK1",1
"R-HSA-418592","R-HSA-418592","ADP signalling through P2Y purinoceptor 1","1/47","17/2914",0.24209473511158,0.315037564391952,0.170111679900687,"MAPK14",1
"R-HSA-5607761","R-HSA-5607761","Dectin-1 mediated noncanonical NF-kB signaling","1/47","17/2914",0.24209473511158,0.315037564391952,0.170111679900687,"RELA",1
"R-HSA-5696394","R-HSA-5696394","DNA Damage Recognition in GG-NER","1/47","17/2914",0.24209473511158,0.315037564391952,0.170111679900687,"YY1",1
"R-HSA-68949","R-HSA-68949","Orc1 removal from chromatin","1/47","17/2914",0.24209473511158,0.315037564391952,0.170111679900687,"CDK2",1
"R-HSA-111885","R-HSA-111885","Opioid Signalling","2/47","59/2914",0.246035273172853,0.318510779998965,0.17198712146178,"MAPK1/CDK5",2
"R-HSA-202403","R-HSA-202403","TCR signaling","2/47","59/2914",0.246035273172853,0.318510779998965,0.17198712146178,"NFKB1/RELA",2
"R-HSA-3371571","R-HSA-3371571","HSF1-dependent transactivation","1/47","19/2914",0.266491449998372,0.34233901653637,0.184853718352447,"EP300",1
"R-HSA-421270","R-HSA-421270","Cell-cell junction organization","1/47","19/2914",0.266491449998372,0.34233901653637,0.184853718352447,"CTNNB1",1
"R-HSA-9029569","R-HSA-9029569","NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux","1/47","19/2914",0.266491449998372,0.34233901653637,0.184853718352447,"EP300",1
"R-HSA-983705","R-HSA-983705","Signaling by the B Cell Receptor (BCR)","2/47","63/2914",0.27020080130777,0.346216372008166,0.18694738440193,"NFKB1/RELA",2
"R-HSA-1980143","R-HSA-1980143","Signaling by NOTCH1","2/47","64/2914",0.276247631402807,0.350448088844288,0.189232395909196,"EP300/NOTCH1",2
"R-HSA-167044","R-HSA-167044","Signalling to RAS","1/47","20/2914",0.278399878962129,0.350448088844288,0.189232395909196,"MAPK14",1
"R-HSA-5339562","R-HSA-5339562","Uptake and actions of bacterial toxins","1/47","20/2914",0.278399878962129,0.350448088844288,0.189232395909196,"MAP2K1",1
"R-HSA-6783310","R-HSA-6783310","Fanconi Anemia Pathway","1/47","20/2914",0.278399878962129,0.350448088844288,0.189232395909196,"ATR",1
"R-HSA-73854","R-HSA-73854","RNA Polymerase I Promoter Clearance","1/47","20/2914",0.278399878962129,0.350448088844288,0.189232395909196,"MAPK3",1
"R-HSA-73864","R-HSA-73864","RNA Polymerase I Transcription","1/47","20/2914",0.278399878962129,0.350448088844288,0.189232395909196,"MAPK3",1
"R-HSA-8936459","R-HSA-8936459","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","1/47","20/2914",0.278399878962129,0.350448088844288,0.189232395909196,"EP300",1
"R-HSA-111465","R-HSA-111465","Apoptotic cleavage of cellular proteins","1/47","21/2914",0.29011902398244,0.362467907768584,0.195722769821465,"CTNNB1",1
"R-HSA-3781865","R-HSA-3781865","Diseases of glycosylation","1/47","21/2914",0.29011902398244,0.362467907768584,0.195722769821465,"NOTCH1",1
"R-HSA-450302","R-HSA-450302","activated TAK1 mediates p38 MAPK activation","1/47","21/2914",0.29011902398244,0.362467907768584,0.195722769821465,"MAPK14",1
"R-HSA-556833","R-HSA-556833","Metabolism of lipids","3/47","119/2914",0.300728309624496,0.369505052554362,0.199522635794666,"CSNK2A1/CSNK2A2/EP300",3
"R-HSA-1266695","R-HSA-1266695","Interleukin-7 signaling","1/47","22/2914",0.301651829330807,0.369505052554362,0.199522635794666,"STAT3",1
"R-HSA-180024","R-HSA-180024","DARPP-32 events","1/47","22/2914",0.301651829330807,0.369505052554362,0.199522635794666,"CDK5",1
"R-HSA-187577","R-HSA-187577","SCF(Skp2)-mediated degradation of p27/p21","1/47","22/2914",0.301651829330807,0.369505052554362,0.199522635794666,"CDK2",1
"R-HSA-2173788","R-HSA-2173788","Downregulation of TGF-beta receptor signaling","1/47","22/2914",0.301651829330807,0.369505052554362,0.199522635794666,"SMAD3",1
"R-HSA-69563","R-HSA-69563","p53-Dependent G1 DNA Damage Response","1/47","22/2914",0.301651829330807,0.369505052554362,0.199522635794666,"CDK2",1
"R-HSA-69580","R-HSA-69580","p53-Dependent G1/S DNA damage checkpoint","1/47","22/2914",0.301651829330807,0.369505052554362,0.199522635794666,"CDK2",1
"R-HSA-9024446","R-HSA-9024446","NR1H2 and NR1H3-mediated signaling","1/47","22/2914",0.301651829330807,0.369505052554362,0.199522635794666,"EP300",1
"R-HSA-201451","R-HSA-201451","Signaling by BMP","1/47","23/2914",0.313001194483453,0.381541602034574,0.206022043750153,"SMAD4",1
"R-HSA-392518","R-HSA-392518","Signal amplification","1/47","23/2914",0.313001194483453,0.381541602034574,0.206022043750153,"MAPK14",1
"R-HSA-1234174","R-HSA-1234174","Cellular response to hypoxia","1/47","24/2914",0.324169974787596,0.391347367153218,0.211316889081578,"EP300",1
"R-HSA-5625740","R-HSA-5625740","RHO GTPases activate PKNs","1/47","24/2914",0.324169974787596,0.391347367153218,0.211316889081578,"AR",1
"R-HSA-69615","R-HSA-69615","G1/S DNA Damage Checkpoints","1/47","24/2914",0.324169974787596,0.391347367153218,0.211316889081578,"CDK2",1
"R-HSA-912694","R-HSA-912694","Regulation of IFNA signaling","1/47","24/2914",0.324169974787596,0.391347367153218,0.211316889081578,"STAT1",1
"R-HSA-354192","R-HSA-354192","Integrin alphaIIb beta3 signaling","1/47","25/2914",0.33516098211804,0.401712086222818,0.216913554279366,"AKT1",1
"R-HSA-9006115","R-HSA-9006115","Signaling by NTRK2 (TRKB)","1/47","25/2914",0.33516098211804,0.401712086222818,0.216913554279366,"CDK5",1
"R-HSA-9006921","R-HSA-9006921","Integrin signaling","1/47","25/2914",0.33516098211804,0.401712086222818,0.216913554279366,"AKT1",1
"R-HSA-1280218","R-HSA-1280218","Adaptive Immune System","6/47","296/2914",0.341648733596998,0.408510776926243,0.220584661561182,"NFKB1/AKT2/RELA/FBXO22/AKT1/AKT3",6
"R-HSA-111996","R-HSA-111996","Ca-dependent events","1/47","26/2914",0.345976985524219,0.410745188975435,0.221791183037476,"MAPK1",1
"R-HSA-350054","R-HSA-350054","Notch-HLH transcription pathway","1/47","26/2914",0.345976985524219,0.410745188975435,0.221791183037476,"NOTCH1",1
"R-HSA-75153","R-HSA-75153","Apoptotic execution phase","1/47","26/2914",0.345976985524219,0.410745188975435,0.221791183037476,"CTNNB1",1
"R-HSA-193704","R-HSA-193704","p75 NTR receptor-mediated signalling","2/47","76/2914",0.348331222344197,0.412562511570786,0.222772487600992,"NFKB1/RELA",2
"R-HSA-174184","R-HSA-174184","Cdc20:Phospho-APC/C mediated degradation of Cyclin A","1/47","27/2914",0.356620711867835,0.41744620711632,0.225409549803329,"CDK1",1
"R-HSA-2122948","R-HSA-2122948","Activated NOTCH1 Transmits Signal to the Nucleus","1/47","27/2914",0.356620711867835,0.41744620711632,0.225409549803329,"NOTCH1",1
"R-HSA-5689603","R-HSA-5689603","UCH proteinases","1/47","27/2914",0.356620711867835,0.41744620711632,0.225409549803329,"YY1",1
"R-HSA-5693571","R-HSA-5693571","Nonhomologous End-Joining (NHEJ)","1/47","27/2914",0.356620711867835,0.41744620711632,0.225409549803329,"BRCA1",1
"R-HSA-69017","R-HSA-69017","CDK-mediated phosphorylation and removal of Cdc6","1/47","27/2914",0.356620711867835,0.41744620711632,0.225409549803329,"CDK2",1
"R-HSA-174178","R-HSA-174178","APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1","1/47","28/2914",0.367094846451212,0.425728051092725,0.229881519342012,"PLK1",1
"R-HSA-179419","R-HSA-179419","APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint","1/47","28/2914",0.367094846451212,0.425728051092725,0.229881519342012,"CDK1",1
"R-HSA-6781823","R-HSA-6781823","Formation of TC-NER Pre-Incision Complex","1/47","28/2914",0.367094846451212,0.425728051092725,0.229881519342012,"EP300",1
"R-HSA-933541","R-HSA-933541","TRAF6 mediated IRF7 activation","1/47","28/2914",0.367094846451212,0.425728051092725,0.229881519342012,"EP300",1
"R-HSA-141424","R-HSA-141424","Amplification of signal from the kinetochores","1/47","29/2914",0.377402033636518,0.432673727349876,0.233631994808106,"PLK1",1
"R-HSA-141444","R-HSA-141444","Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal","1/47","29/2914",0.377402033636518,0.432673727349876,0.233631994808106,"PLK1",1
"R-HSA-176409","R-HSA-176409","APC/C:Cdc20 mediated degradation of mitotic proteins","1/47","29/2914",0.377402033636518,0.432673727349876,0.233631994808106,"CDK1",1
"R-HSA-1980145","R-HSA-1980145","Signaling by NOTCH2","1/47","29/2914",0.377402033636518,0.432673727349876,0.233631994808106,"EP300",1
"R-HSA-5673000","R-HSA-5673000","RAF activation","1/47","29/2914",0.377402033636518,0.432673727349876,0.233631994808106,"MAP2K1",1
"R-HSA-4641262","R-HSA-4641262","Disassembly of the destruction complex and recruitment of AXIN to the membrane","1/47","30/2914",0.387544877455958,0.443287633802363,0.2393632143864,"CTNNB1",1
"R-HSA-196854","R-HSA-196854","Metabolism of vitamins and cofactors","1/47","31/2914",0.397525942213091,0.452637493292633,0.244411883131015,"AKT1",1
"R-HSA-4791275","R-HSA-4791275","Signaling by WNT in cancer","1/47","31/2914",0.397525942213091,0.452637493292633,0.244411883131015,"CTNNB1",1
"R-HSA-6782135","R-HSA-6782135","Dual incision in TC-NER","1/47","32/2914",0.407347753075381,0.462769216078834,0.24988273669978,"EP300",1
"R-HSA-199991","R-HSA-199991","Membrane Trafficking","3/47","144/2914",0.41267900489166,0.467765116404348,0.252580386418568,"AKT2/AKT1/AKT3",3
"R-HSA-168638","R-HSA-168638","NOD1/2 Signaling Pathway","1/47","33/2914",0.417012796658121,0.468438141537486,0.252943801607593,"MAPK14",1
"R-HSA-6782210","R-HSA-6782210","Gap-filling DNA repair synthesis and ligation in TC-NER","1/47","33/2914",0.417012796658121,0.468438141537486,0.252943801607593,"EP300",1
"R-HSA-69052","R-HSA-69052","Switching of origins to a post-replicative state","1/47","33/2914",0.417012796658121,0.468438141537486,0.252943801607593,"CDK2",1
"R-HSA-76009","R-HSA-76009","Platelet Aggregation (Plug Formation)","1/47","33/2914",0.417012796658121,0.468438141537486,0.252943801607593,"AKT1",1
"R-HSA-112040","R-HSA-112040","G-protein mediated events","1/47","34/2914",0.426523521599832,0.474862854047813,0.256412970879899,"MAPK1",1
"R-HSA-112043","R-HSA-112043","PLC beta mediated events","1/47","34/2914",0.426523521599832,0.474862854047813,0.256412970879899,"MAPK1",1
"R-HSA-3214847","R-HSA-3214847","HATs acetylate histones","1/47","34/2914",0.426523521599832,0.474862854047813,0.256412970879899,"EP300",1
"R-HSA-5687128","R-HSA-5687128","MAPK6/MAPK4 signaling","1/47","34/2914",0.426523521599832,0.474862854047813,0.256412970879899,"CDK1",1
"R-HSA-373752","R-HSA-373752","Netrin-1 signaling","1/47","35/2914",0.435882339129279,0.483135070583559,0.260879741863588,"MAPK14",1
"R-HSA-446728","R-HSA-446728","Cell junction organization","1/47","35/2914",0.435882339129279,0.483135070583559,0.260879741863588,"CTNNB1",1
"R-HSA-195253","R-HSA-195253","Degradation of beta-catenin by the destruction complex","1/47","37/2914",0.454153713161973,0.500068154492634,0.270023144667732,"CTNNB1",1
"R-HSA-212165","R-HSA-212165","Epigenetic regulation of gene expression","1/47","37/2914",0.454153713161973,0.500068154492634,0.270023144667732,"EP300",1
"R-HSA-3899300","R-HSA-3899300","SUMOylation of transcription cofactors","1/47","37/2914",0.454153713161973,0.500068154492634,0.270023144667732,"EP300",1
"R-HSA-1592230","R-HSA-1592230","Mitochondrial biogenesis","1/47","38/2914",0.463070910062003,0.506546999871317,0.273521544210376,"MAPK14",1
"R-HSA-3108214","R-HSA-3108214","SUMOylation of DNA damage response and repair proteins","1/47","38/2914",0.463070910062003,0.506546999871317,0.273521544210376,"BRCA1",1
"R-HSA-373755","R-HSA-373755","Semaphorin interactions","1/47","38/2914",0.463070910062003,0.506546999871317,0.273521544210376,"CDK5",1
"R-HSA-913531","R-HSA-913531","Interferon Signaling","2/47","97/2914",0.468097353014759,0.510929790545521,0.275888131463807,"STAT1/MAPK3",2
"R-HSA-6781827","R-HSA-6781827","Transcription-Coupled Nucleotide Excision Repair (TC-NER)","1/47","39/2914",0.471845481420517,0.513901274329737,0.277492651544789,"EP300",1
"R-HSA-4086398","R-HSA-4086398","Ca2+ pathway","1/47","40/2914",0.480479659637294,0.522169868716452,0.281957466666936,"CTNNB1",1
"R-HSA-5653656","R-HSA-5653656","Vesicle-mediated transport","3/47","160/2914",0.481941092895737,0.522624431906416,0.282202918373671,"AKT2/AKT1/AKT3",3
"R-HSA-109704","R-HSA-109704","PI3K Cascade","1/47","42/2914",0.497335595869739,0.532404131475938,0.287483689020519,"AKT2",1
"R-HSA-2980736","R-HSA-2980736","Peptide hormone metabolism","1/47","42/2914",0.497335595869739,0.532404131475938,0.287483689020519,"CTNNB1",1
"R-HSA-418346","R-HSA-418346","Platelet homeostasis","1/47","42/2914",0.497335595869739,0.532404131475938,0.287483689020519,"MAPK14",1
"R-HSA-6783783","R-HSA-6783783","Interleukin-10 signaling","1/47","42/2914",0.497335595869739,0.532404131475938,0.287483689020519,"STAT3",1
"R-HSA-69618","R-HSA-69618","Mitotic Spindle Checkpoint","1/47","42/2914",0.497335595869739,0.532404131475938,0.287483689020519,"PLK1",1
"R-HSA-909733","R-HSA-909733","Interferon alpha/beta signaling","1/47","42/2914",0.497335595869739,0.532404131475938,0.287483689020519,"STAT1",1
"R-HSA-416476","R-HSA-416476","G alpha (q) signalling events","3/47","165/2914",0.502869357450137,0.537180273097054,0.290062675041376,"MAPK3/MAPK1/RPS6KA2",3
"R-HSA-1430728","R-HSA-1430728","Metabolism","5/47","289/2914",0.505534534426737,0.538878301591054,0.290979564048536,"CSNK2A1/CSNK2A2/STK11/EP300/AKT1",5
"R-HSA-69239","R-HSA-69239","Synthesis of DNA","1/47","44/2914",0.513655903566644,0.546372840099551,0.295026410138848,"CDK2",1
"R-HSA-73887","R-HSA-73887","Death Receptor Signalling","2/47","106/2914",0.515550726663456,0.547226512835576,0.29548737009926,"NFKB1/RELA",2
"R-HSA-112399","R-HSA-112399","IRS-mediated signalling","1/47","46/2914",0.529457244836258,0.559616201820601,0.302177463741768,"AKT2",1
"R-HSA-5696399","R-HSA-5696399","Global Genome Nucleotide Excision Repair (GG-NER)","1/47","46/2914",0.529457244836258,0.559616201820601,0.302177463741768,"YY1",1
"R-HSA-8953854","R-HSA-8953854","Metabolism of RNA","2/47","109/2914",0.53076394467044,0.559816286905033,0.302285504222279,"MAPK14/AKT1",2
"R-HSA-1989781","R-HSA-1989781","PPARA activates gene expression","1/47","47/2914",0.537168370879736,0.563015384541313,0.304012929566378,"EP300",1
"R-HSA-5663220","R-HSA-5663220","RHO GTPases Activate Formins","1/47","47/2914",0.537168370879736,0.563015384541313,0.304012929566378,"PLK1",1
"R-HSA-877300","R-HSA-877300","Interferon gamma signaling","1/47","47/2914",0.537168370879736,0.563015384541313,0.304012929566378,"STAT1",1
"R-HSA-400206","R-HSA-400206","Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)","1/47","48/2914",0.544755774635806,0.569775872844548,0.307663408595543,"EP300",1
"R-HSA-2428928","R-HSA-2428928","IRS-related events triggered by IGF1R","1/47","50/2914",0.559567155867481,0.582833981475276,0.314714430589654,"AKT2",1
"R-HSA-8957275","R-HSA-8957275","Post-translational protein phosphorylation","1/47","50/2914",0.559567155867481,0.582833981475276,0.314714430589654,"MEN1",1
"R-HSA-2404192","R-HSA-2404192","Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)","1/47","51/2914",0.56679492949675,0.586703015863372,0.31680360348122,"AKT2",1
"R-HSA-2428924","R-HSA-2428924","IGF1R signaling cascade","1/47","51/2914",0.56679492949675,0.586703015863372,0.31680360348122,"AKT2",1
"R-HSA-8951664","R-HSA-8951664","Neddylation","1/47","51/2914",0.56679492949675,0.586703015863372,0.31680360348122,"FBXO22",1
"R-HSA-388396","R-HSA-388396","GPCR downstream signalling","7/47","436/2914",0.568779479081931,0.587543338185665,0.317257354582868,"MAPK3/AKT2/MAPK1/AKT1/CDK5/AKT3/RPS6KA2",7
"R-HSA-400253","R-HSA-400253","Circadian Clock","1/47","52/2914",0.573906574035225,0.59161973990051,0.319458500166889,"EP300",1
"R-HSA-163685","R-HSA-163685","Integration of energy metabolism","1/47","55/2914",0.594562852412095,0.611655008333593,0.33027699788157,"STK11",1
"R-HSA-2467813","R-HSA-2467813","Separation of Sister Chromatids","1/47","56/2914",0.601227961169224,0.617244279806929,0.333295051812965,"PLK1",1
"R-HSA-1500931","R-HSA-1500931","Cell-Cell communication","1/47","57/2914",0.607785793858184,0.622700782664519,0.336241414318272,"CTNNB1",1
"R-HSA-5663205","R-HSA-5663205","Infectious disease","2/47","126/2914",0.610918022319243,0.624632508534573,0.33728449352534,"CTNNB1/MAP2K1",2
"R-HSA-68882","R-HSA-68882","Mitotic Anaphase","1/47","60/2914",0.626832402576073,0.639598846620392,0.345365907304214,"PLK1",1
"R-HSA-2555396","R-HSA-2555396","Mitotic Metaphase and Anaphase","1/47","61/2914",0.632977769457266,0.643249213992069,0.347337005979539,"PLK1",1
"R-HSA-381426","R-HSA-381426","Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)","1/47","61/2914",0.632977769457266,0.643249213992069,0.347337005979539,"MEN1",1
"R-HSA-6806834","R-HSA-6806834","Signaling by MET","1/47","62/2914",0.639024052259757,0.648079048951697,0.349944984936624,"STAT3",1
"R-HSA-376176","R-HSA-376176","Signaling by ROBO receptors","1/47","64/2914",0.650825595053935,0.658714390145498,0.355687778689764,"ABL1",1
"R-HSA-372790","R-HSA-372790","Signaling by GPCR","7/47","486/2914",0.689892475247798,0.696847036490216,0.376278366168685,"MAPK3/AKT2/MAPK1/AKT1/CDK5/AKT3/RPS6KA2",7
"R-HSA-2219530","R-HSA-2219530","Constitutive Signaling by Aberrant PI3K in Cancer","1/47","72/2914",0.694369541422437,0.699958028677346,0.377958216976737,"ESR1",1
"R-HSA-3858494","R-HSA-3858494","Beta-catenin independent WNT signaling","1/47","76/2914",0.714101315648177,0.718403130802684,0.38791806831871,"CTNNB1",1
"R-HSA-983168","R-HSA-983168","Antigen processing: Ubiquitination & Proteasome degradation","1/47","88/2914",0.766110375719635,0.76918095838785,0.415336708279604,"FBXO22",1
"R-HSA-983169","R-HSA-983169","Class I MHC mediated antigen processing & presentation","1/47","115/2914",0.851599490133186,0.853302689113452,0.46076014518785,"FBXO22",1
"R-HSA-418594","R-HSA-418594","G alpha (i) signalling events","2/47","217/2914",0.876182770983096,0.876182770983096,0.473114764455627,"MAPK1/CDK5",2
